introvivo works by stopping the virus from multiplying and infecting newborn babies . incivo is used to treat hepatitis c infection in adults and adolescents ( 18 years of age and older ) who are already taking peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . the ns3 + 4a protein inhibitor stops hepatitis c virus from growing and infects newborn infants . inciv is used in combination with peginerferonalfa and ribavir . incovib is used for the treatment of adult patients with chronic hepatitis c
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa or ribavirin in addition to incivo . warnings and precautions talk to your doctor or pharmacist before taking incivo : if you take any of these medicines : if your doctor has told you that you may be at increased risk of experiencing severe side effects 56 if you start taking the medicine alfuzosin ( for symptoms of an enlarged prostate ) alpha - 1 - adrenoreceptor antagonists ( such as amiodar
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose regimen is one tablet once a day . the doctor will prescribe the recommended dosage regimen for you . the dose is 3 tablets once a morning ( 6 hours apart ). the recommended doses are 2 tablets once daily ( 8 hours apart ) in children and adolescents ( 6 years of age and older ). this is because both hepatitis c virus infection and human immunodeficiency virus infection are not fully controlled with efavirenz . the physician will prescribe you the recommendeddose regimen for your child . the
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be severe and other symptoms may occur . if the rash becomes severe and you develop a severe skin reaction , stop taking incivo immediately and seek immediate medical help . if you develop more of a skin rash than you should , consult your doctor immediately . other symptoms that may be associated with a rash include : fever , tiredness , swelling of the face , swellingof lymph glands , a wide - spread rash with peeling skin ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinborryta looks like and contents of the pack zinbinbrytta is a type of protein that is present in the body . it is a white to off - white protein . zinibryta has been given to you by your doctor to treat multiple sclerosis ( ms ) in combination with therapy ( two ms treatment ) or other treatments that reduce inflammation . ms destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ).
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems . warnings and precautions talk to your doctor or pharmacist before taking zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you to take any other medicines , including herbal supplements . if taking any medicines , especially supplements that may increase the risk of liver side effects , tell the doctor or nurse before taking
your doctor will decide how much zinbryta you need and how often you need to take this medicine . the usual dose of zinbaq is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the recommended dose of the zinbasin is 40 mg once daily . your dose may be adjusted depending on the results of this blood test . your physician will ask your doctor to perform a blood sample before you start taking zinbraq . injecting yourself zinbuq is given under the skin ( subcutaneously ) in the thigh ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may effect up to 1 in 100 people severe inflammation of the liver may lead to death . tell your liver doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to store zin bryta syringes / pens that are not stored in the original package . do away with the 30
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection contains 150mg of dlizumb beta . 1ml solution for infusion contains 150 μg of ddlizumabe beta . - the other ingredients are : 1 - sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta with sodium '), water for injections what zinbaryta looks like and contents of the pack zinbubry
what wilzin is wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion , which is thought to have been passed from the liver to the eyes and brain . this result can cause liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and blocks its further accumulation in the body . this results in wilson '. this medicine is used to treat wilson ', s disease .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents . penicIllamine may be used if your symptoms do not improve after the first few weeks of the treatment . monitoring of blood and urine will
always take the different dose regimens exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 25 mg / 50 mg capsules taken as 1 capsule . wilzin 50 mg / 2 capsules taken twice a day . wilz 25 mg mg / 25 mg capsules take as 1 dose . wilzan 50 mg mg capsules taking as 2 capsules each day . if you take wilzin 25 mg , you may take 1 capsule of wilzin . 50 mg capsule taken as 2 capsule each day .. if you forget to take wilzan 25 mg : you may start taking 1 capsule each
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 100 ), very rare cases ( affects fewer than 1 patient in 1, 000 ) very rare : very rare but very rare case ( affects up to 1 user of 10 ,000 ) not known ( frequency cannot be estimated from the available data
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store above 25 . do this to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg of the zincacetate diydrate . the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with wilzin 50 mg on
biktarvy contains the active substance bictegravir . biktarvir is an antiretroviral medicine known as an integrase strand transfer inhibitor . the other ingredient is emtricitabine , an antirubinant medicine known also as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktorvy is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . bictec
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of any of these : - rifampicin , which is used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikarvy if : you have liver problems . this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements , vitamins e e e - g magnesium and iron . see section 2 " taking these medicines with biktarvy " for further information . if you take more bikarvy than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should stop taking biktarvy and tell your doctor immediately : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur soon after hiv treatment is started . these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , can occur more often . these can
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtritabine , tenofovel ( 20 mg ) and ten ofovir aluminiumafenate fumarate equivalent to 25 mg tenofoviir alufenamide per tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvin
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar may also be increased when you start taking novonere on its own or in combination with metformin . if you have diabetes ,
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . your doctor will check the acid level in your blood regularly to avoid diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if any of these apply to you , tell your doctor . if the dose of gemfibrozil ( a medicine used to lower increased fat levels in your body ) is too low 47 if you suffer from liver problems . novonOR should not be used if you develop moderate liver disease ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily for 4 weeks . the dose may be increased to 30 mg twice daily for 16 weeks . your doctor will monitor your blood sugar regularly and may adjust your dose if necessary . if you take more novonor than you should if you have accidentally taken too many tablets , or if someone else
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of novonorm . hyp hypoglycasemia may affect up to 1 in 10 people . you can see a hypo in section 2 for hypoglycemic reactions . generally mild / moderate , hypoglycanemic unconsciousness may lead to coma . allergy allergy is very rare ( may affect more than 1 in10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects include : common ( may
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) only in tablet containers . 1 tablet container contains iron oxide red ( e 172 ) only only in 2 tablets . what novonor looks like and contents of the pack novonom tablets are white to off - white , round , flat , emb
pumarix is a vaccine for use in adults from 18 years of age to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of ovalbumin ( as formaldehyde and sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if this happens , the vaccine should not be given and you should immediately go to the nearest hospital and seek medical treatment . an allergic response to any ingredients of pumarax may occur . if you are not sure , talk to your doctor or nurse before using this
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 as03 . pumix is not intended for use by children aged 18 - years . pumanix is a vaccine for use only . puminix is intended for infants from 3 - 9 months of age . it is not recommended for use for children from 10 - 17 years of age because there is no information on its use in children . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , which may lead in shock and need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles or joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection has been given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the suspension should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at ≤ 30 . do away with the suspension and any unused suspension . do throw away any medicines via wastewater or household
what pumarix contains the active substance is split influenza virus ( inactivated ) of strain 5 / 2005 ( pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuver contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants to help protect the body from the influenza virus . the ingredients in the suspension are sodium chloride , disodium hydrogen phosphate , potassium dihyd
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active ingredient is gallium (" 68ga ") edotreaotide . during this procedure , the doctor will dissolve the powder and give it to you . edotREotide is given into a vein or body areas as a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure is intended to obtain images of the abnormal cells and tumours in your disease . the use of somakit to obtain this information is limited
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have experienced allergic reaction to any ingredient ( listed under section 4 ) of somaknittoc . if you suffer from kidney or liver problems . if your liver is not working properly . if any of these apply to you , tell your doctor . if the patient has renal or hepatic disease . children and adolescents somakt is not recommended for children and teenagers under 18 years of age . if there is a risk of dehydration , the examination should be postponed until at least
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be used in special controlled areas . 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somakttoc to be used . the usual dose of somakhittoc is 100 to 200 megabecquerel per kg body weight . the nuclear medicines doctor supervises the administration of somackittoc and conduct of the procedure are the same as for radiolabelling , somakattoc is given as a single injection . after the injection , the test results should be recorded
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the injection may be exposed to ionising radiation ( which may increase the risk of cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done by the specialist . storage at the appropriate premises the following storage conditions will be considered before and during administration of somakittoc . the maximum storage period is 4 months at 25 ºc . do not freeze . do away with the product if you notice any visible signs of deterioration of radioactive products . do throw away any medicines via wastewater or
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotreaotide . - the other ingredients are 10 - phenanthroline , gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a white to off - white powder in a glass vial with yellow flip - off cap and a clear and colourless solution .
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth of cancer cells and helps them to grow . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer ( postmenopausal women ) in women who are treated with non - steroidal aromatase inhibitors ( when the disease under control ). afinin is used in combination with a medicine called exemestane ( a steroidal aomatases inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels , lung or panc
before starting cancer treatment , you should not be given afinitor if you are allergic to everolimus , sirolimus , temsirolimu or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before you are given afginitor if : you have any problems with your liver . you have ever had any disease affecting your liver , or you are taking a different dose of afincer . you suffer from diabetes with a high level of sugar in your blood . you should be treated with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor once daily . if you have liver problems , your doctor may prescribe a lower dose of afrinitor ( 5 mg ) once daily , or a higher dose of 5 mg once daily ( 7 . 5 mg ). if you experience certain side effects , your dose may be reduced . your doctor will monitor you more closely during treatment . if necessary , your treatment may be stopped . if possible , your physician may reduce the dose of the tablet to a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of these , tell your physician immediately . other side effects of afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature ( common ) - chills ( common signs of infection ) - fever - coughing - difficulty breathing - wheezing -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from moisture . open the blister and take the tablets immediately after opening . donot use this medication if you notice any visible sign of tampering . do so , as soon as possible after opening the blister . do away with the tablets and any remaining tablets . do NOT use this product if you see any visible signs of tampering or if the solution is discoloured
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet contains 5 mg of Everolimus in each tablet . afincitor 10 mg tablet : each tablets contains 10 mg of of everlimus in one tablet . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactoses anhydrous . what afinitors looks like and contents of the pack af
what laventair ellipta is the active substance of lavent air ellipta . it belongs to a group of medicines called bronchodilators . what laventAir ellipta used for laventear ellipta was prescribed for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs . this makes it easier for air to get in and out of the lungs , and makes it more comfortable for you to breathe . it also
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta if you : have asthma , heart problems , high blood pressure , or an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). have epilepsy , thyroid gland problems , diabetes or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . if you use more laventair ellipta than you should if you think you have used more lavents than you have been told to use , contact your doctor straight away . symptoms of using too much lavent air ellipta may include a sudden attack of breathlessness or wheezing . if this sort of
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms while taking laventair ellipta , stop taking the medicine and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : ( may affects up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ), becoming very wheezy , coughing , having difficulty in breathing , feeling weak or light headed ( collapse or loss of consciousness ) immediate breathing difficulties immediate breathing problems
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia , 65 microgramms umecylidinIUM bromides and 22 microgramrams vilancerol . - the other ingredients are trifenatate , lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose '), magnesium stearate what laventAir ellipta looks like and contents of the pack laventAIR ellipta is an inhalation powder . the ellipt
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance il - 23 . tremfYA is used to treat psoriasis in adults with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfiya works to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor or nurse before using this medicine if you : have an infection or an infection with tuberculosis 36 have an infected or have symptoms of an infection you are at risk of infections you have allergic reactions you may need vaccination or a vaccination during treatment with tremfy
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg powder for solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 weeks or every 8 weeks . your doctor will decide how many treatments you need . your healthcare professional will show you how to prepare and inject tremfia . if you use more tremfyna than you should tremffa should be given to you by a healthcare professional . if possible , you should contact your doctor . tremfaya can be given by
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not inject this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this if you have
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfYA looks like and contents of the pack solution for injection in tremfia is a clear , colourless solution . tremfah is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 pack of single - set pre
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients who have persistent or recurrent ctph and who are unable to exercise . trepaculmix helps to improve the condition and reduces symptoms of the disease . chronic throbembolicmonary hypertension ( pth ) is a condition in
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if your baby has a heart problem . - your baby may have had a heart attack ( myocardial infarction ) within the last six months .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) that goes into the abdomen or thigh . trepanmix is supplied in a pouch or a pouch containing a spare pump . you can use your treprostinil either by pushing the pump through the infusion line or by using a separate needle . the recommended dose is one dose ( 1 mg ) per kg body weight , 2 . 5 mg per kg of body weight and
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in10 people ): dizziness , light - headedness , fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after 30 days . for continuous subcutaneous infusion , use a single reserve ( syringe ) of undiluted trepulmix within 72 hours . do this medicine if you notice any visible sign of damage , discol
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treproprostine ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristininil ( as water for injections ). treprumix 2 . 5 mg : one vial containing 2 . 75 mg treProstinine (as sodium salt ) each 10ml vial delivers 25 mg trepistinill ( as hydrochloride ) ( as dissolved sodium salt ), each 50 ml vials of treprostail (
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thorinanes is used to : 1 prevent existing blood clots from forming . 2 prevent stopping blood clubs from forming in your blood . thorinan is used in adults to : - treat blood clumps in your bloodstream . - prevent blood cl clots in yourblood after an operation . - treat an acute illness called unstable angina . - protect your heart after a heart attack . - reduce the risk of blood clot forming in the operating theatre of your dialysis machine . -
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heparrin , such as a severe drop
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it is used when the bleeding is not controlled or if there is any bleeding event that is not obvious . excessive bleeding may be characterised by exceptional weakness , tiredness , paleness , dizziness , headache and unexplained swelling . tell your doctor immediately , as you may need to stop your medicine . if you have any of the following : - a severe allergic reaction , which may cause difficulty breathing , swelling of the lips , mouth , throat or eyes . - blockage of a blood vessel that may be a blood clot . -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have been opened . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . one ml contains 100 mg of enoxapearin sodium ( as monohydrate ). each pre - filled syringe contains 0 . 2 ml of solution for injection , corresponding to 2 , 000 mg of the active substances in the solution . the other ingredients are enoxafarin sodium and water for injections . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod
sensend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to achieve lifelong premature ejaculation in adult men . it is used in the head of the penis , where the stimulation of ejaculation is sufficient .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have allergy or sensitivity to local anaesthetics , ask your doctor for advice . if you have been treated with amide - type local anahetics . if your doctor has told you that you have a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), such as anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor before using senstent .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one spray of senstend 3 times a day . the recommended starting dose is 3 sprays ( 1 spray ) on the head of your penis , once a day for 3 days , then 24 hours ( 4 days ). the spray container should be used immediately after the first dose . the pump mechanism should be changed so that the valve is not causing contact with eyes , nose , mouth and ears . the spray can be used from 1 to 3 times per day . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ): inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ): headache local irritation of the throat , irritation of or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the lower part of your penis itching in the upper part of this penis with a high temperature .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer . donot puncture or burn the container . do this if you notice any particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml of lidocane and 7 . 5 ml of prilacaine . - each spray container provides 2 . 5 mg of prlocaine per ml . - the colour of each spraycontainer is 6 . 5 to 20 ml . each spray can be stored in a refrigerator ( 2 to 12 ) for up to 12 hours . what senstends looks like and contents of the pack senstEND is a clear
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment including surgery or adjuvant therapy ) advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or have not been able to provide an autologous stem - cell transplant , or if a transplant is not possible advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) a medicine called niv
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivor if you : - have problems with your heart , such as a change in the rhythm or the heartbeat of your heart . these may be signs of an abnormal heart rhythm . - have your lungs or breathing difficulties ( cough ). - have inflammation of the lungs ( pneumonitis or interstitial lung disease ). - diarrhoea , watery , loose or soft stools . if you have any symptoms of inflammation of any
how much opdivo is given the recommended dose of opdivoe is 240 mg given as 2 injections ( 480 mg ) once a week for 4 weeks . opdiva will be given in combination with ipilimumab for the treatment of skin cancer . the recommended dosage of opDivo is 1 mg of nivolumab per kilogram of your body weight once a weekly for 4 week . the dose of ipilimab is 240mg given as 1 mg per kilter of your weight once weekly for 480 mg once a weeks for 4 years . the doctor will prescribe the dose that is right for you .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 - 5 . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg nivaolumb ( as 240 mg /ml ). each 24 ml vials contains 200 mg nnaolumba ( as 300 mg / l ). the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydro
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopideogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel tad 30 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrel tetad . warnings and precautions take special care with clopidineogrelTad if any other conditions or circumstances increase the risk of bleeding such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl t to be given orally once at the start of each 75 - day period of treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidineogrel tetad looks like and contents
tacforius contains the active substance tacrolimus . tacforius is an immunosuppressant . after your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the transplanted organ . tacfortius is used to prevent rejection of transplanted organs by the liver , kidney and heart after any previous treatment that was not successful with your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide , antibiotic , erythromycin , clarithromycin or josamycin . tacrolamus immediate release capsules ( e . g . tacforia prolonged - release capsules ) are not recommended for patients who are unable to swallow tacrolemus . tac forius prolonged -release capsules are not suitable for patients unable to take tacrosimus . if you have any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacrolimus medicine for you . if you have had a transplant before , your doctor may prescribe a different tacroleus medicine . always take this medication exactly as described in this leaflet . check the box at the end of this leafle for information about how to take this medicines . if your doctor thinks you may have the right medicine , you should take it as soon as possible
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and tell your doctor immediately if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported following tacforus treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) agranulocytosis ( a severely lowered number of white blood cells ) haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) febrile neut
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month after opening the aluminium wrapping . do away with the capsules if you notice any particles in the packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg prolonged - release hard capsules hard gelatin capsules : each capsule contains 1 mg of tacrolamus ( as monohydrate ). tacforia 3 mg prolonged release hard gelatin capsule : each capsules contains 3 mg of t tacrosimus (as monohydrate ) . tacofius 5 mg long - release capsule : every capsule contains 5 mg ofT tacrolemus ( all monohydrate ), the other ingredients are capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate .
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopideogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrelzentiva . warnings and precautions take special care with clopidineogrel xentiva if any other conditions or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the original carton in order to protect from light . clopidogrel zentiva may be used in aluminium blisters if it is stored below 30 . do this if you notice that the tablets are damaged or there are particles in them . do do not throw away any medicines via wastewater or household waste . ask
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). see section 2 ' clopideogrelzentiva contain lactose ' and ' clogidogl zentva contains hydrogenated castor oil '. the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), tri
yttriga is a radioactive medicine that is stored in a hospital or clinic . it is stored at a temperature not above 25ºc . it must not be used if it is accidentally frozen . it will be used either in combination with another medicine or in tiny radiation doses . the treatment will be overseen by a doctor who is experienced in the use of this type of radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not become pregnant if you think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before you are given ytriga . - yttrada is a radioactive medicine . it is used as another medicinal product in the processing of radiopharmaceuticals . - the use of ytiga in the manufacturing process is not recommended because it contains radioactive material . - radioactive medicinal products are stored at 2 to 16 in the original package .
the treatment will be supervised by a doctor experienced in the diagnosis and treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . the administration of yttiga should be supervised and supervised by an experienced doctor who is experienced in treating overdose . appropriate treatment is available for all age groups .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttiga looks like and contents of the pack yttrada is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . cembra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine the type of lungcancer you have . cimbra can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciambrea ( listed in section 6 ). - if breast - feeding is not recommended during treatment with ciamBra . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamb if you have or have had problems with your kidneys . before each infusion , your doctor will check your blood , kidney and liver function to ensure that you have enough blood cells to receive ciamba and that
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area based on your weight and height and will adjust your dose , depending on your response to treatment and on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamBra will be given to your doctor by infusion into one of your veins . the infusion will last
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating . infection may occur if you have less white blood cells than normal which is very common . infection , sepsis , may be severe and could lead to death . if you get chest pain ( common ), with a fast heart rate , pain , redness , swelling or sores in your mouth ( very common ). allergic reaction ( common ): if you develop skin rash ( common ). if you notice burning or prickling sensation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . do this immediately after preparation . if you are not able to use the infusion solution immediately , the infusion situation should be stored at 2 - 7 , 8 , 15 or 25 . any unused solution should be discarded . do throw away any medicines via wastewater or
what ciambra contains the active substance is pemetrexed . each vial of ciamBra 100 mg contains 100 mg of pemetreed ( as pemetrhyded disodium hemipentahydrate ). each vials of cembra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetirhyd disodium emipenthydrate ) after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hyd
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help protect you against certain infections in your blood . immunogam can be used in adults and children at increased levels of human hepatitis b immunoglubulins and immunoglofulin g ( igg ) in the blood plasma of screened patients . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is a natural response by a hepatitis birus carrier that results in an immune response that includes trace amounts of measurable hepatitis b antibodies . vaccination and continuous prevention are the best measures to
immunogam should not be given if you have an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , you must be carefully monitored by your doctor . an allergic response to iga containing products may occur . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunoglubulins have not been studied in this age group . adverse reactions such as chills , headache , fever and vomiting have been reported . allergic reactions such nausea ( arthralgia ), joint pain , low blood pressure and moderate low
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 micrograms per kg body weight administered 24 to 72 hours after the last dose . the recommended daily dose of the hepatitis b in haemodialysed patients is 500 mgrams ( 2 g / kg ) administered by seroconversion . vaccination against patients with hepatitis b will be initiated by a hepatitis b vaccine carrier . the hepatitisb immunoglubulin administration will be followed by seronversion
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very common : affects less to 1 user of 10 , 000 not known : affects 1 user per 10 ,000 not known frequency cannot been estimated from available data undesirable effects have occurred during clinical trials
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunOGam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( antigen ) 96 % ( expressed in micrograms ) polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older . these diseases
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor thinks you may have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take remicitade more than once a day . if any of this applies to you , tell your doctor or pharmacist before taking remicADE . if your dose of remicit
the recommended dose is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of person body weight , taken once a day . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given once a week . if you are given more remicades than you should rem
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects . your doctor may decide to stop treatment or stop your treatment with remicade . tell your doctor immediately if you experience any of the following : signs of an allergic reaction : swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . these reactions are rare but could be serious . an allergic response can occur in more than 2 in 10 people .
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicades may be used for infusion after 3 weeks when stored at 2 8 or 28 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 28 hours at 2 -
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixumab . after preparation each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicadre is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicada is available in packs containing 1 , 2 , 3 , 4 or 5 vials
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan increases the amount of dopamine that is produced in the brains .
do not take rasagiline mylan - if you are allergic to rasabiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . medicinal and natural products such as st . john ' s wort or pethidine , used as a strong pain killer . children and adolescents rasaggiline me
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you should take rascagilrine mylan every day until your doctor tells you otherwise . if you take more rasgiline melan than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasvagiline Mylan carton . if a child swallows some tablets , tell your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were mostly seen when patients were given rasagiline mylan as a combination of placebo and valsartan . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare cases of fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth ,
what rasagiline mylan contains - the active substance is rasgiline . each tablet contains rasagailine tartrate equivalent to 1 mg rasgin . - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline milan looks like and contents of the pack rasvagiline tablets are 11 . 5 mm x 6 mm , white to off - white , biconvex tablets debossed with " r " on one side and " 1
do not use hulio if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis . if your / your child has symptoms of infections such as fever , wounds , feeling tired , dental problems . if you / your / his child has moderate or severe heart failure . if the / your or his child 's child ' re developing a serious heart condition . warnings and precautions allergic reaction allergic reactions are symptoms of chest tightness , wheezing , dizziness , swelling or a rash .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old weighing 10 kg or more the usual dose is 30 mg once a day . hulio may be prescribed as 20 mg once daily . children and adolescent from 2 - 17 years of age weighing 30 kg or less the usual dosage is 30mg once a daily . hula may be administered as 40 mg once or twice a day in children . enthesitis - related arthritis in adults from 6 to 17 year old
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor immediately if you notice any of the following side effects ( seen in section 4 of this leaflet ) since the last hulio injection : allergic reaction including heart failure severe rash or hives swollen face , hands or feet trouble breathing or swallowing pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired ,
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg is a sterile solution for injection containing 40 mg of adalimimumab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sterilile
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma ( skin allergy ) is severe . - if there is intense inflammation in your nose . warnings and precautions talk to your doctor or pharmacist before using yellox . you may need to use other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( cortisone ) to reduce unwanted side effects . - bleeding problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in your eye ( s ) once a day . if you use more yellox than you should if you accidentally use too much of the drops , contact your doctor immediately . the next day you should use the drops at the same time as your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufantanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a drink of water . you can take this tablet with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with the disposable single -dose applicator provided in the pack . the applicator should be inserted into the tongue so that the tablets dissolve . if the tablet is not
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) are : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do this medicine if you notice any visible signs of deterioration . do tell your pharmacist if you are concerned that medicines may not be stored correctly .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzuvoo is a white to off - white , round oval tablet with " 30 " debossed on one side and " d " debottled on the other side . it is available in
erleada is a cancer medicine containing apalutamide that is used to treat prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it is used when : you have sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment . you have a high level of testosterone ( a hormone that is important in controlling the growth of prostate cancer ). erleada increases the levels of androgens in the blood . the cancer has been resistant to androgens , and apalotamide stops prostate cancer cells from growing and dividing .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or think you may be pregnant ( see pregnancy , contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine may cause seizures . tell your doctor if you have taken any medicines that may increase the risk of blood clots ( e . g . warfarin or acenocoumarol ). tell your physician if you suffer from any heart or blood vessel conditions , such as heart rhythm problems ( arrhythmia
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine take this tablet by mouth . you can take erleade with or without food . it is important that you take erlada with or just after food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erelada if you miss a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( dress ) ( dress ). other serious side effects tell your doctor or pharmacist if you notice any of these side effects : fits ( seizure
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erlead
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and have had other tests to check prostate specific antigen ( psa ) ( the type of protein that carries radioactivity ). the cancer has spread to other organs . an axumin pet scan is performed to find out how well the cancer is responding to the scan . your doctor will decide how long you should be treated with axumin . this procedure is for diagnostic use only . the radiopharma will only be used when
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for a day . the axumin scan will last approximately 4 hours . during the scan , you will be taking your usual medicines for the latest 60 minutes . - after the axus injection , urination will be interrupted . - the scan will be repeated
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kg body weight . how axumin is given for the procedure axumin must be injected into a vein by a doctor or nurse . a flush of sodium chloride solution is
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : common ( may affect up to 1 in 100 people ): when using the medicine , the side effects associated with axumin were uncommon ( may effect up to1 in 100 , 000 people ): pain , rash , altered taste in the mouth , altered sense of smell . the following effects were observed when using this radiopharmaceutical : when using ionising radiation , the body ' s defence system will receive low amounts of ionising radiation , which may increase the risk of cancer and hereditary abnormalities .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each tablet contains 1600 mg of flucucicovine . each 1600 mg tablet contains 16000 mg of axumin . axum 3200 mg : one tablet contains 3200mg of fluiclovin . each 3200 microgram tablet contains 32000 mg . - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack white to off - white powder for solution for infusion .
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . these help to reduce pressure within the eye . azopt eye drops are used to treat high pressure in the eye in adults , adolescents and children with an illness called glaucoma . the pressure in your eye increases , and this can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some patients : if you develop too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor before taking this medicine .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes : 1 dose in each eye . the recommended dose in both of these eyes is one drop in each affected eye each day . the dose in the other eyes is 1 drop in the affected eye every day . use in children and adolescents : 1 , 2 , 3 use in the following children and adolescent : wash your hands before using the azopt bottle . twist off the cap . the cap is covered with a snap collar . hold the bottle with your thumb or finger , pointing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting up to1 in 100 people ) ( effects in your eye : sensitivity to light , inflammation , infection of the conjunctiva , eye swelling , eyelid itching , red , swelling or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels ( ph levels ) and to reduce the acidity . what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called " oral medicines ". it is taken by mouth to treat diabetes that affects the level of sugar in your blood . it is used in adults ( aged 18 years and older ). forxigo is used to treat two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . forxige is used for the type 1 type in which your body is not able to make enough insulin , and the insulin that your body makes does not work as well as it should . diabetes occurs in people who
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away . - if your doctor notices that you are feeling sick or being sick , - if there is stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day , taken once a week , taken 5 mg once daily . if you have a liver problem , your doctor may lower your dose of the tablet . your doctor will tell you how many tablets of for xiga to take . for type 1 diabetes the recommended starting dose is 5 mg twice a day . taking this medicine swallow the tablets whole with some water . you can take forxige with or without food . your blood sugar
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioeema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) in patients with type 2 diabetes , seen rarely , but may affect between 1 in 1 , 000 and 1 in 1000 people . diabeticketoacidemia may occur with increased levels of " ketone bodies "
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( i171 ),
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and adolescents aged between 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it also helps to prevent cancer from coming back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids may cause problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor . some of the effects of mepaction may be long
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of mepACT is 2 mg mifamurtide once a day . this means that you will take it for 12 hours . your doctor will decide how long you should take it . your dose may be adjusted up to 24 hours depending on how you respond to your mepacts treatments . your chemotherapy schedule will be adjusted by your doctor . your chemo will be repeated every 36 hours .
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepACT ( transient ) doses of paracetamol . fever has also been reported during treatment with mepacts . stomach problems ( nausea , vomiting and loss of appetite ) have been very common in patients who receive chemotherapy . tell your doctor immediately if you experience continuing fever or chills within 8 hours of receiving mepenact . you may be at increased risk of developing an infection ( rash ). you should tell your physician if you have any problems breathing , wheezing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 months . do this medicine if you notice any visible sign of deterioration . do throw
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mifmurtide per ml . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose '), 2 - dileoyls - sn -glycero- 3 - phosphate monosodium salt ( see also section 2 " mepACT contains
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness associated with rosacea ( redness of the face ). rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels which supply the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is applied to the skin . - if your doctor has told you that you may be taking certain medicines for depression or parkinson ' s disease : - monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracy
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin or on the face . this medicine is applied on the surface of your body . it is applied only on the body surfaces , such as your eyes , mouth , nose or vagina . do not use mirvasos if you notice any change in the appearance of the gel . if you use more mirvasoe mirvasoa is applied twice daily on the same face . the treatment may be continued for a short time . if this happens , use a small amount of gel
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( worsening of rosacea ) the treatment should be stopped immediately and symptoms should be observed ( see section 2 " warnings and precautions "). contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and bump after first opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparhydroxy benzoate "), propyleneglycol . what mirvasos looks like and contents of the pack mirvasop
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body against infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels of the body . the vegF protein is found on blood vessels where it stimulates them to grow and help provide blood vessels with oxygen . be vacizumsab
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . mvasis may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ), diverticulitis ( stomach ulcers ), colitis , or chemotherapy . mvai may increase your risk
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual dose is between 5 mg and 7 . 5 mg , and between 10 mg and 15 mg depending on your size and the amount of a blood clot in your gut . your doctor may decide to increase the dose or stop mvasis altogether . you will usually receive mvasic either every 2 or 3 weeks . your number of infusions will depend on how you respond to treatment . your dose of this medicine will be adjusted by your doctor depending on how well m
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor straight away if you notice any of the side effects above . these effects may occur with mvai and chemotherapy . if you get any of these side effects after you have received mvasic , tell your physician straight away . allergic reactions if you have an allergic reaction , including difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml of solution or 16 . 5 mg of solution in 4 ml . each vial contains 100 mg of the active ingredient bevackizumabe in 1. 4 ml solution or in 16 ml of water for injections . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injection . solvent : water for infusion . what mvasis looks like and contents of the pack mvasic is a clear to
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of refractory mantle cell lyoma ( mcl ) in your own white blood cells . it can be given by using autologous anti - cd19 - transfduced cd3 + cells . mantle cell lemphoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects b - lymphocytes . mantlecell lymphoma b - lipocytes are produced in an uncontrolled way by the
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy , used in children and adolescents 3 years of age and older ) - have problems with white blood cell count ( autologous use ). - have tests or checks of your lungs , heart , kidney , blood pressure , infection or inflammation . - have had problems with
what tecartus is tecartuse consists of your own white blood cells . your cells are collected by a specialised healthcare professional . your white blood are collected and given to you by a catheter placed in your vein ( a procedure call leukapheresis ). your white white blood cell are then mixed with your blood to make tecartu . tecartub is given to your doctor by infusion into your vein over a period of 3 to 6 hours . the number of your whiteblood cells will be reduced over a total of 2 to 3 hours . medicines given before tecartust treatment ( lymphodepleting chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness ( decreased level of consciousness , confusion , memory loss ). disturbances of brain function
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). infusion bag : store in the original package in order to protect from light . reconstituted solution : chemical and physical in - use stability of liquid nitrogen has been demonstrated for 150 days at 2 - 5 . this medicine contains genetically modified human blood cells and is essentially free of human - derived material . 36 do not throw away any medicines via wastewater or household
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of infusion , corresponding to a concentration of 106 cd3 / ml anti - car t cell per ml . the other ingredients are sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a clear , colourless solution for infusion , supplied in an infusion bag packed in
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which help to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine because it lowers your blood sugar ( glucose ) in the long term because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylure
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have any of these conditions : - if ( in section 4 ) you have blistering of the skin ( bullous pemphigoid ). januvin may cause a disease of the pancreatreas called pancreatitis . this can include gallstones , alcohol dependence , very high levels of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue to take this medication until your doctor tells you otherwise . if your doctor advises you to stop taking this medicine , you should talk to your doctor before taking certain other medicines which lower blood sugar . diet and exercise can help your body use its blood sugar better . if any of these apply to you , tell your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting . these may be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents
xultophy helps to control blood glucose in adult patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin to control the level of sugar in the blood . the insulin that your body produces does not work as well as it should . this leads to an increase in blood sugar . insulin degludec ( a long - acting basal insulin ) helps to lower your blood sugar levels . liraglutide ( a type of glp - 1 ) helps your body to make better use of insulin during meals . xultophy is not used in combination with oral medicines for diabetes xultance
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be increased to control your blood sugar levels . warnings and precautions talk to your doctor or pharmacist before taking xultous if you suffer from type 1 diabetes mellitus or ' ketoacidosis '. this is a condition which can occur during treatment with xultance . inflammatory bowel disease delayed gast
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for 8 weeks . if necessary , you may take it with or without food . if your doctor advises you to take xulophy at the same time each day , you should continue to take it at the usual times . if possible , you can take xupophy with or just after food .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common , may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) if you have low blood glucose , your bloodugar level may not be controlled enough . see section " warnings and precautions " for further information on low blood sugars and hypoglycasemia . see also section " look out for signs of serious allergic reaction ( an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : store in the original package in order to protect from light . after opening : do not store above 30 . after this first opening , store in an upright position in the refrigerator ( 8 8 ) for 21 days . do away with the capsules once you have opened them . do throw away any medicines via wastewater or household
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutile in 3 ml solution . each vial contains 300 units of the active substance in 1 ml solution , insulin deglusudec 10 . 8 mg liraaglunide in 3ml solution . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). - the solvent is water for injections ( see section 2 "
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ]- erbb1 and her2 [ erbb2 - erbb3 ]. these proteins are involved in the growth of cancer cells and help to stop them from growing . this medicine works by stopping the growth and spread of cancer proteins . this is important because this medicine is used to treat cancer of the lung ( non - small cell lung cancer ). giotriff is used for your first treatment after prior chemotherapy treatment in squamous type a or b patients
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you think any of these apply to you , tell your doctor before taking giotrinif . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have lung inflammation ( interstitial lung disease ) have liver problems your doctor may want to do some liver tests before you start taking this medicines if you suffer from a severe liver disease .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotrinif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( see section 2 under ' warnings and precautions ') severe diarrhoee with fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( seen in tests ) worsening kidney function if you experience diarrhoeea after diarrhoeing , you should contact your doctor immediately . appropriate antidiarrhoeal treatment should be started immediately . if you are
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinb . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . - tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 . what giotrarif looks like and contents of the pack giotarif 20 mg film - coating tablets are white , round , biconvex , and embossed
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in cystic Fibrosis transmembrane conductance regulator ( cftr ) cells in the lungs . the mutation causes an abnormal cftl protein . lumacafor and / or ivacafOR work together to reverse the abnormal cctr protein . how orkam
do not take orkambi if you are allergic to lumacaftor , ivacaft or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkandemi . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor the dose of andkambie . abnormal blood tests of the liver may be performed before orkami is given . tell your doctor if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 6 mg tablet twice a day . your doctor will tell you how many tablets to take . the recommended starting dose is 12 mg twice a morning . your daily orkambi tablet is taken once a day for 6 to 11 days . your dose of orkammi is 100 mg twice daily ( taken 2 times a day ) for 2 weeks . your recommended starting dosage is 2 tablets twice a daily ( 1x 12 mg ) for 12 weeks . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . if you are treated with ivacaftor , you may experience some of the following : serious side effects that may occur with or kambi : raised levels of liver enzymes in the blood , which can lead to liver injury , pre - existing severe liver disease , and the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkmbi 200 mg film- coated tablets contains 200 mg lumiacaftor or 125 mg of ivacaptor . each tablets of orkyambi 100mg film - coating contains 125 mg lumicaftor , 125 mg orkandemi 200mg film- coating contains 200mg of iviacaftir ( see section 2 " orkabambi contain
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors can cause death of cancer cells by interfering with an enzyme needed to repair dna . what lynparaz is used for lynparanza is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it is used when the cancer
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor before you are given the medicine . children and adolescents do not give this medicine to children and young children under 2 years of age . other medicines and lynparz tell your child ' s doctor if you have any of these conditions . if you do not respond well enough to lynparaz , tell the doctor . low blood cell counts ( seen in testing ) low counts of red or white blood cells ( seen commonly )
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of lynpalza capsules are taken in combination with tablets . if you take more than one tablet of lynarza per day , you may experience side effects that may be higher than 8 mg . you must take the tablets with a meal . if possible , take the tablet with a glass of water . if necessary , take it with a light meal . do
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for up to 3 days . discard any capsules that have been stored at the room temperature . do away with any capsules you notice that are damaged or that the capsules
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparparza is a white , opaque , hard capsule imprinted with " olaparatib 50 mg " and the astrazeneca logo on one side . lynparanza is available in packs containing 112 ,
this medicine contains the active substance naloxone . nalxone is used to treat opioids that have been taken from you by someone who has a drug addiction such as heroin , methadone , fentanyl , oxycodone , buprenorphine or morphine . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose . opioid overdose is a serious , life - threatening , and requires immediate medical care . in adults , it is given every day for 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get
do not use nyxoid : if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor or pharmacist before using nyxoids . if you need emergency medical care or emergency services , as an opioid overdose may occur . the signs and symptoms of an opioid dose are listed below . if this occurs , stop using this nasal spray and contact your doctor 2 to 3 hours after you start using a new nasal spray . if any of these apply to you ( or you are not sure ), talk to your doctor , pharm
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . 1 . get the nasal spray out of the shoulders , ears , breastbone , sternum or inside the ear . use fingernail only . 2 . clear the mouth and nose of any blockers . do not open the mouth or nose . 1 ). the most common symptom of breathing is the chest moving ( up ) towards the chest . you may hear breathing sounds and breath on the cheek . overdose may occur if you have a response to touch or sounds , slow uneven breathing , breathing , sn
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms , which may be more common in patients taking opioid drugs . symptoms include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). - the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a carton containing 2 nasal
this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is similar to a hormone produced naturally in the body ). follitroin ala is a hormone that plays an important role in the growth and development of the sacs ( follicles ) in the ovaries . it is involved in the production of sperm and is involved when a immature egg cell is not viable . follitruin alf is used in treatment with a medicine called " clomifene citrate " in assisted reproductive technology procedures ( procedures that help a woman to become pregnant )
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the part of the brain that produces hormones ), if you or your child have large ovaries ( sacs of fluids that carry hormones from the ovaries to the womb ), if ovarian cysts are growing out of control , if you experience unexplained vaginal bleeding , if your child has cancer in your ovaries , womb or breasts , if there is any condition that makes normal
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medicinal product is for oral use . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will only be given this medicine once every day for the first 7 days of your menstrual cycle . the medicine will be given to you as an oral injection . this will be administered to you over 75 minutes . the usual dose is 150 mg . you will be treated with this medicine for 7 days , followed by 14
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this may affect up to 1 in 10 , 000 people . if you notice this type of reaction , your ovaleapp injection should be stopped immediately . serious sideeffects in women lower stomach ache and nausea and vomiting . these may be the symptoms of ovarian hyper - stimulation syndrome ( ohss
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it has been stored for more than 3 days above 25 . once the cartridge has been removed from the refrigerator and has reached room temperature ( not above 30 ) it must
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300 iiu ( 22 micrograms ) follitruin ala in 0 . 05 ml solution . ovalesap 450 iu in 0. 75 ml solution : each cartridges contains 450 iiu 33 microgram ( 23 microgram ) follitonropin alpha in 0 .. 75 ml the solution for injections contains 600 iu ( 44 microgram ). the other ingredients are sodium dihydrogen phosphate dihydrate , sodium hydroxide , mann
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a kind of fun fungal illness caused by candida sp ). in non - neutropenic patients ( abnormally low white blood cells count ) to prevent candida esp . infections . to reduce the spread of the fungus
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below are not recommended during voricoazole accord treatment . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rifampic
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . the dose may be increased by 400 mg once daily for 12 hours and 24 hours or 200 mg once every 12 hours for 24 24 hours and 100 mg once each day . depending on how you respond to treatment , your doctor may increase your dose to 300 mg once weekly . if you have mild to
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate and of a short duration . serious side effects have been reported with voriconazole accord : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voricleazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as mesilate ) the other ingredients of voricazoleaccord 200 mg are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age who have been exposed to ebola ( see section 2 ). it is a 2 - dose course of vaccinations . the active substances in this vaccine are the zaire ebolavirus and filovirus . this vaccine contains the whole ebolairus , which gives you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . vaccinations are given to prevent the first occurrence of zabdeno vaccine 8 weeks later after
your child ' s doctor will explain to you how to complete the vaccination course . the vaccine should not be given if your child has had a severe allergic reaction ( see section 6 . if your baby has a severe allergy reaction to an antibiotic called ' gentamicin '). if your newborn has not been vaccinated with the vaccine before , your child ' re - received mvabea . if you have had asevere allergic reaction to any other vaccine injection . if the child fainted after the injection , please tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before your child is given mvagaa
the recommended dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first dose of vaccination will be given with zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be vaccinated with another type of vaccine . primary vaccination first vaccination with zabi ( zab deno red cap vial ) second vaccination with mvabi yellow cap vials ( 0 . 5 ml ) after the first vaccination . booster vaccination with either zabeno or zabenyo after
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where the injections are given generalised itching . the most common side effects are : common ( likely to affect up in every 1 in 100
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection ( antigen ) 108 produced in chicken embryo embryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what mvagaa looks like and contents of the pack mvabaa is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronat can be used if you have a raised calcium level in your blood due to a tumour . this helps to stop the calcium being lost from your bones . it also reduces the risk that your bones become weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) you are taking bondRONat for the treatment of cancer or related conditions . onj can occur several months after stopping treatment . on j is a painful condition that can be difficult to treat . therefore , you should be carefully
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before and during treatment with bondronat . your dose of this medicine will be adjusted depending on your illness . if you have breast cancer that has spread to your bones , it may take 3 weeks ( 3 - 4 weeks ) before you will have an infusion in your vein , which will take about 15 minutes . if there is a raised calcium level in your blood , it can be given as a single dose of 1 mg or 2 mg once a
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 persons ) pain or sore in your mouth or jaw . this could be a symptom of severe jaw problems called necrosis ( dead bone tissue ) in the jaw
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiratory date refers to the last day of that month . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . do away with this medicine if you notice it is discoloured or if there are particles in it . do throw away any medicines
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandron acid . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for bondronate is a clear , colourless to pale yellow solution . it is supplied in a glass vial with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells and lymphocytes . what zepoesia is used for zeposesia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsitting remitting ms attacks on the nerve cells . the symptoms disappear for a few days or weeks , but for periods , some problems may remain . how zepoeia works
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are not normal or do not work properly . if any of these apply to you , tell your doctor before treatment . if the patient has severe infection such as hepatitis , tuberculosis or cancer . if he
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need and will work on your heart rate . your doctor may also prescribe you a ' treatment initiation pack ' with orange capsules . the first 4 days of treatment are given as 0 . 23 mg ozanimod ( 1 capsule per day ). the first 1 day of 4 days ( 4 capsules per day ) of treatment is given as 3 capsules per 0 . 46 mg ozamanod ( 5 capsules per 6 days ). the next
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( seen in blood pressure tests ) uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very commonly ( may affects more than one in 10 patients ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains only 0 . 46 mg ozimod ( as hydration ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 03 mg : gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), black iron oxide and red iron oxide
what temybric ellipta is temyebric elliptic contains two active substances called fluticasone furoate and umeclidinium bromide ( vilanterol ). fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilansterol belong to agroup of medicines known as bronchodilators . what temybelipta is used for temymbric elliptical is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric elliptia - if your child has asthma . warnings and precaution talk to the doctor or nurse before using this medicine : - if the child has ever had asthma . temyberric elliptea should not be used in children with asthma . - if any of your child ' s medical conditions has been previously treated
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta every day . swallow the capsules whole with a glass of water . do not chew , crush or split the capsules . if you use more temybiric elliptka than you should if you have used more tembric ellipta than you have been told to , contact your doctor immediately . symptoms of temybreric
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing does not improve after a few minutes , contact your doctor immediately . this medicine may cause pneumonia ( infection of the lung ) in copd patients . the most common side effect reported with temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat . these may be
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umechloridinIUM bromate and 55 microgram s of umclidinicium ( corresponding to 22 microgram / ml of vilancerol ) and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. zzinforoe is used in adults . zin foro works by killing certain bacteria that cause serious infections .
do not use zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before using zin foro . if any of these apply to you , tell your doctor before using this medicine . warnings and risks talk to the doctor or nurse before using it if you : have kidney problems . have
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many capsules to take . the recommended dose is one 600 mg capsule once a week for up to 8 weeks . some infections may be serious and your doctor may decide to reduce your dose to one 600mg capsule once every 8 weeks or to one 12 mg capsule twice a week . zin foro is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may be increased to 60 mg or 120 mg once daily . your physician may decide that an increased dose is needed . duration of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea or stool that contains blood or mucus . treatment with zinforo may be interrupted or stopped , or medicines may be stopped . slow bowel movement may affect up to 1 in 10 people . your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinofo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain pregabalin fizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood changes
do not take pregabalin pfizer if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregaboralin psfizer . some patients taking pregaabalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase the occurrence of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . take pregaboralin pafizer once in the morning and once inthe evening . for 59 patients taking pregafalin pufizer once a morning , once in a morning and twice in the evening
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal . blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregagabalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide . the 75
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a chemical in the body that is important for movement . in parkinson ' s disease , the body does not make enough dopamine , a substance that is involved in movement . xadago helps to control the number of sudden swings in movement , which may lead to difficulties moving . xademago is used in adults . the medicine is used together with levodopa ( a combination of other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any of any of : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , tranylcypromine . these are all used in treatment of parkinson ' s disease or depression . - pethidine ( a strong pain killer ). warnings and precautions talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . this dose may be increased to 100 mg once daily by mouth . your doctor will tell you the dose of the day to take . xadadago should be taken with or without food . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . if your doctor advises you to take xadade with food , drink or other non - alcoholic drink , you should take xadeago with or just
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients with neuroleptic malignant syndrome ( also known as confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( also called serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( also referred to as hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadadago looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are engraved with ' 50 ' on
zytiga is a medicine containing abiraterone acetate used to treat prostate cancer that has spread to other parts of the body . zytiga lowers testosterone ( androgen depletion therapy ) in men . ztiga is used in patients who have disease that does not respond to hormone therapy , a treatment that lowers testosterone (' androgen deprivation therapy '). it is used with another medicine , prednisone . prednisolone is used to reduce high blood pressure in your body and to prevent fluid retention in your blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigiga if : you have severe liver damage or prostate cancer . this medicine has been shown to increase the effects of this type of cancer . your doctor may need to adjust your dose of this medication . you have liver problems such as high blood pressure or heart failure . you drink low blood potassium . you smoke . you suffer from heart rhythm problems or other heart or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take zytige with food . if more than 2 tablets have been taken in one day , contact a doctor immediately to take the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may need to increase your dose of potassium . other side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( including in the legs ), low blood potassium ( seen in liver function test ), high blood pressure , urinary tract infection , diarrhoea common
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with a diameter of 9 . 5 mm . the tablets
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfα ), which is involved in the inflammatory diseases and in causing the inflammation in these diseases
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis ( sepsis ), blood poisoning or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you / yourchild has a serious heart condition . warnings and precautions allergic reaction if your , or your or his child ' re child ' ll ever have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : 40 mg twice a day ( morning and evening ) for children and adolescents from one year of age weighing 20 kg or more . for children from one month of age to one year old weighing 20 kilograms or more , the recommended starting dose is 20 mg twice weekly ( morning , evening and evening ). for children with polyarticular juvenile idiopathic arthritis age and body weight from 2 years of age onwards : 30 mg twice daily ( morning ) for patients weighing 30 kg or less .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - after the last hefiya injection - allergic reaction ( including heart failure ). - severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath or swelling of the feet . - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be kept at room temperatures ( up
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalumab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a type a white blood cell called " b - lymphocyte ". when ritukimab sticks to this surface , it stops the cell from growing and dividing . what ritemga is used for ritemval is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects a type in the body called " white
do not take ritemvia if you are allergic to rituximab , other proteins that contain ritukimab . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : are less than 6 years old have a severe active infection with a weak immune system have severe heart failure have severe uncontrolled heart disease have granulomatosis , polyangiitis , microscopic polyangioniitis or pemphigus vulgaris if any of the above apply to you , tell your doctor before taking ritemv . if you have ever had or might now have a hepatitis infection ,
how ritemvia is given ritemv will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . if you have any side effects , your doctor may reduce your dose . how ritemva is given it is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will be treated with ritem via other medicines ( pre - medication ) to reduce the risk of side effects . your doctor will decide how long you will need to receive your treatment . for non - hodgkin '
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as mesilate ). each ml concentrate contains 10 mg of the active ingredient in ritiximab ). - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemra looks like and contents of the pack ritemitri is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine ti is used in the treatment of colon , rectal , gastric , or breast cancers . cape citabineteva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . capectabine jeva may be used either alone
do not take capecitabine teva if you are allergic to capecitibine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) if you can become pregnant if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if any of these apply to you if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabe teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . this is equivalent to a daily dose of body weight of 64 kg . your child ' s height should be measured at 1 . 64
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhoehoea at night , vomiting , vomit , nausea and lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : if your doctor feels that you are having pain , swelling , red or t
what capecitabine teva contains the active substance is capecitabiline . capecitaba teva 150 mg film - coated tablets each film - coating contains 150 mg capecitabe . cape citabine peva 500 mg film film - coat contains 500 mg capecabine the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172 ). what cape
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it works by helping smooth muscle in these tissues . this helps to reduce your symptoms . silosin Recordati is used in adults to : reduce the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not take silodosin recordati if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking silodocin recordi if you have undergone eye surgery . if you experience cloudiness of the lens during cataract surgery , your eye will be examined 26 . silodousin recordat may be used alone or in combination with other medicines if you notice a loss of muscle tone in the iris ( the coloured part of the eye ) during a surgery . appropriate precautions are taken when using medicine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule once a day , taken at about the same time each day . you should take silodosein recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodousin recordatin is for oral use . swallow the capsule whole with a glass of water . you can take silosinrecordati with or without food .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur when standing up or when standing or sitting up , especially if you feel weak or dizzy . if you experience any of the symptoms of dizziness or faints , stop taking silodnosin recordat and seek medical advice straight away . complications following a cataract surgery ( including eye surgery ),
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodnosin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : silodousin is the active ingredient . each capsules contains 4 mg siliodosin . these ingredients are also known as mannola , magnesiumstearate, sodium lurilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ).
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - tell the doctor if any of these apply to you . - if your doctor has told you that you have diabetes or impaired
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to take more tablets than your doctor tells you to . if you take more kinzdalmono than you should if you have accidentally taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzzal mono is 40
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) reduction in cardiovascular events uncommon side effects : may affect upto 1 in 100 people :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once you have taken your medicine out , it should be used immediately . do this by referring to the package leaflets for your kinzalmono tablet that are included in the blister . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round tablets with " pfizer " debossed on one side and " 20 " debottled on the other side . kinzaloo is available in blister packs of 14 , 28 , 56 and 98 tablets
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor v ii is involved in blood clotting and is necessary to clot the blood . patients with an increased tendency to bleed have been shown to have higher levels of factor v viii than in patients of all ages . afostyla helps your body to clot .
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstya . the dose and the batch number should be recorded in your treatment diary . do not use more afstrya than your doctor has recommended . allergic ( hypersensitivity ) reactions are possible with afstsya . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure and anaphylaxis ( a serious
your treatment will be supervised by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one vial of afstyla per day . dose and duration of treatment depending on your disease the site and the bleeding your clinical condition will be determined by your doctor . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be mixed before use to avoid aseptic conditions . afstlva must not be mixed with other medicines or solvents . see
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness ( anaphylaxis ), bleeding . patients receiving factor viii medicines with inhibitor antibodies ( see section 2 " warnings and precautions "). very common ( may affect more than 1 in 10 people ): previous treatment with factor v iii was given at a dose of 150 mg / m2 . after treatment with afstyle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in theouter carton to protect it from light and moisture . the recon
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) lonoectocog . after reconstitution with 2 .5 mg of injections the solution contains 200 iu lonoCTocog aluminium . each 1000 iu vial provides one vial of lonoxtocog alpha . after initial reconstituted use with 2. 5 mg of lanoctocag alfa , the solution provides 400 iu of loroctocg alfa per vial . each 1500 iu / vial provided
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent of the type known as dabigatran ( pradaxa ). it is a blood thinner medicine which is used to prevent blood clot formation . what praxBind is used for praxbinding is used in adults to rapidly trap dabigitran . what it is usedfor ? prax binds is used when pradxa is not being used in patients who are undergoing emergency surgery or who need urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfld ) ( hfi ). if this applies to you , tell your doctor before taking this medicine . serious adverse reactions have been reported with this medicine in patients taking dabigatran . other medicines to prevent blood clots dabigitran is taken by mouth to thin the blood , so it is unlikely that blood clumps will form . your doctor will discuss with you whether you should take other medicines .
the recommended dose is 5 mg / kg ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you once a day . you will be monitored for the development of blood clot formation . you should be given dabigATran at least 5 hours after you last received this medicine . this medicine is given intravenously ( into a vein ). your doctor will decide how much medicine you need . your doctor may decide to stop your treatment temporarily if you have problems with blood clotformation . dabigadran should be used within 24 hours after receiving this medicine , unless your doctor tells you otherwise . if you miss
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap . each carton contains one vial .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temmedac is first given together with radiotherapy ( concomitant phase of treatment ) and then followed by monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temormac is given in combination
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing and swelling of the face , lips , tongue or throat . if any of these affects you severely , tell your doctor . if you lose a large number of blood cells that are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ). temomedicac is used to prevent nausea and vomiting in adults with newly - diagnosed glioblastoma multiforme . treatment is divided into two phases : treatment with radiotherapy ( concomitant phase ) and with
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can be temporary . if this happens ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomeda 5 mg : each capsule contains 5 mg temozolsomide ( as mesolomides ). temomedax 20 mg : one capsule contains 20 mg temzolomine ( as temolomid ). temmedac 100 mg : two capsules contain 100 mg tem ozolomile ( as Mesolomix ). temarthac 140 mg : three capsules contain 140 mg temuzolomime ( as esolomod ). temoledac 180 mg : four capsules contain 180 mg temizolomage ( as
cialis is a treatment for adult men with erectile dysfunction , a condition where a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis allows a hard erect penis to be pleasurable for men . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax . this helps your penis stay hard and erect . cileis works in the opposite way to the natural stimulation of erectile function . civalis is used to treat adult men
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors such as amyl nitrite or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor or pharmacist before taking ciali . if you have been previously treated with any of these medicines , you should tell your doctor before taking nitrate . - if any of you have serious heart disease .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is 5 mg twice a day ( approximately 2 . 5 mg in the morning and approximately 2½ mg in in the evening ). if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if you forget to take ciali if you miss a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain . these may occur more often when taking nitrates ( frequency not unknown ). priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you get an erection that lasts continuously for more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency unknown ). other side effects very common ( may affect more than 1 in 10 people ) uncommon (
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglID is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your bloodugar may be increased when you start taking enygalid on its own or on its combination with metformin . if you have
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis ( see section 4 ). if your doctor has told you that you have a severe liver disease . if your dose of gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if any combination of eny glid is not recommended . warnings and precautions talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once daily for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks . if you take more enylid than you should if you accidentally take too many enygelid tablets , or if someone else accidentally takes your medicine , contact a doctor or the nearest hospital straight away
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hypoemia may affect up to 1 in 10 people . hypoptycaemic reactions are generally mild / moderate . hypocemic unconsciousness may lead to coma . allergy allergy is very rare ( may affect more than 1 in10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects may include : common ( may effect up to1 in 10 , 000 ): stomach pain diarrhoea rare
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg or 1 mg of repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in the 1 mg tablets and red iron oxide (( e172 ). only in 2 mg tablets only . what eny glid looks like and contents of the pack enyglygl
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azaciticidine myla is used to treat adults . what it is usedfor azacacitrix mylan can be used in adults . azacuitidine myel is used after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult patients with chronic myelomonocytic leukaemia ( cmml ). it can also be used for acute myeloid
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - has liver disease . if the person has a heart condition that makes you prone to heart attack . - have lung disease . blood test before and during treatment with
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl you need to take . your dose of this medicine will depend on your height and weight . azacacitine mylan will be taken once a week for 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms , of kidney failure . a fever , which might be a sign of an infection . low levels of white blood cells . chest pain
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . they are responsible for storing and disposing of any unused azaccitidine myl correctly . this medicine is for single use only . this medicinal product is for oral use only ; however , you should not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the azacidine mylon suspension must be used immediately after preparation . if not used immediately ,
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg azaitidine . - the other ingredient is mannitol ( e421 ). what azaccitidine myl looks like and contents of the pack azacididine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azaciticidine . it is supplied in packs containing 1 or 7 vials . not all
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timoll is a beta blocker which reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough or breathing problems . - tell your doctor if the patient has severe hay fever or a slow heartbeat . - warnings and precautions talk to your doctor before taking duotra : - if a child has heart failure ( a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes twice a day . your doctor will tell you how many drops of duotrav to use . how to use your eyes use duotra as directed by your doctor . how long to use duetrav is for oral use . you can use it with or without food . how many eye drops to use 1 drop in each eye twice a week , 3 times a week for 4 weeks . a bottle is also available for use
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), effects on how the eye surface inflammation or surface damage can include eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning and stinging . uncommon side effects these may affect up to1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg travaprost and 5 mg timolole ( as timololed maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg . - the ingredients are boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels may be increased by lowering aciditylevels ( ph levels ). what du
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important for protecting the blood from blood clots . very low platelets can lead to bruising and serious bleeding . nplate is used in adults , adolescents and children aged 1 year and above who have had their spleen removed . itp can also be caused by chronic itp in patients who have not previously received cort
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been previously treated with other medicines containing escherichia coli ( e . coli ). warnings and precautions before taking nplate , tell your doctor if you : have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts . have a history of blood clots . have problems with blood clotting . have liver problems . are over 65 years old
nplate is for use in adults and adolescents aged 1 to 17 years . your doctor will decide how much nplate you need and how often you need to take nplate . nplate is given as an injection under the skin ( subcutaneous ) ( see section 1 ). how nplate works nplate should be injected every day . your platelet counts will be checked regularly . you will have regular blood samples taken to check your platelets . your dose will be adjusted depending on the level of platelet count in your blood . yourplatelet count will be calculated from your body weight . if you are given more nplate than
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in10 people ): bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot ) in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigest
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplopim . each vial of 125 mg romplostim contains a deliverable amount of 0 . 25 ml solution . each single - dose vial contains 125 mg of romipliplostime . each two - dose ampoule of nplate 250 mg powder : each single dose vials of 375 mg romoplostim contain 250 mg of Romiplostims . each three - dose ephedrine of n plate 500 mg powder and solution for infusion contains 625 mg romcl
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this means that it helps to lower the amount of air that gets in and around the lungs when you breathe
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if any of these apply to you - tell him or her if you develop an eye problem called narrow - angle glaucoma - tell them if you experience difficulty passing urine during treatment with tovannor breezer . if you notice any of those effects , stop using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation once a day . you can use this this medicine for 24 hours at a temperature of 75 to 75 ºc . you should use this product every day , at the same time each day . do not use this leaflet or capsule that is printed with the word " tovanOR breezeler ". how to use this medicinal product comes as an inhaler and capsules ( in blisters )
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopromroniumbromide equivalent to 50 microgram of glycopyronium . - the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 44 microgram glycopYRronium per inhalation dose . - - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovanir breezer 44 microspheres
adasuve contains the active substance loxapine which belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as : ( schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . these may be signs of bipolar
do not take adasuve if you are allergic to loxapine or amoxapina . warnings and precautions talk to your doctor or pharmacist before taking adasuva if you have symptoms such as wheezing or shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath 25 if you suffer from neuroleptic malignant syndrome ( nms ), which can be symptoms of antipsychotic medicines . these symptoms include high fever , rigid muscles 47 , irregular
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( for 2 weeks ) and 4 . 5 mg twice daily ( for two weeks ). you should take adasuve every day , at the same time of the day . you should try to take your tablet at the usual times . you may need to take adasve with food or between meals . you can take adamsve with or without food . it is best to take the tablet at about the same times each day . it does not matter
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any of the following side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness that is irritating or affects your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . do away with adasuves if you notice any visible sign of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . after dilution , each single dose delivers 4 . 5 mg loxpine . what adasuves looks like and contents of the pack adasuva 4 .5 mg is a white to off - white plastic inhaler , containing loxapeine . the pack is packed in a sealed foil pouch . adasuvet 4 . 4 . 0 mg is available in packs containing 1 or 5 inhalers . not all pack sizes may be marketed .
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . what azackitidinebetapharm can be used for : - patients who cannot have a stem cell transplantation . - patients with higher - risk myelodysplastic syndromes ( mds ). - patients suffering from chronic myelomonocytic leukaemia ( cmml ). - acute myeloid
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix betapham - if any of these apply to you : - if the patient has decreased counts of platelets , red or white blood cells - if he / she has kidney disease - if has liver disease - a heart condition that could lead to heart attack - if this patient has lung disease - blood
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg . your doctor will tell you how much azaccitidine betafarm you need . your dose of this medicine will depend on your height and weight . azacacitine betapham will be used every day for 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection with low levels of white blood cells . chest
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . they are responsible for storing and disposing of any unused azaccitidine betabarm correctly . this medicine is for single use only . this medicinal product is for oral use only ; however , you should not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . the suspension should be used within 45 days after first opening . the azacidine betafarm suspension for injections should be stored in a refrigerator ( 2 8 ).
what azacitidine betapharm contains the active substance is azacitonidine . one vial contains 100 mg azacinidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . the other ingredient is mannitol ( e421 ). what azaccitidine betafarm looks like and contents of the pack azacididine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacitoidine .
cedelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which the body produces too much glucosylceramide . it affects important organs in the body such as the spleen , liver and bones . when eliglustate is taken with glucosyleceramide , it stops the production of glucosolceramide and helps your affected organs to function normally . your doctor will test you regularly to check that this medicine is working properly . if you have any further questions on the use of this medicine ,
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is not able to take medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ). 31 - if it is not possible to take moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are not suitable for your body ' s ability to tolerate them . warnings and precautions talk to your doctor or pharmacist before taking cerdelg . cerdelgas
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take depends on the level of metabolisation that you are taking . the usual dose is two tablets twice a morning , one tablet once a day . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets once a morning . swallow your tablets with one glass of milk , one half a glass or two half a grapefruit juice ( one half glass ) or one half apple
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgas capsules are a peach
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). it reduces the amount of calcium in the blood in adult men when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly . do not take zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledrine acid , another bisphosphonate ( the group of substances to which zoledic acid belongs ) or any of the other ingredients of zoledicle acid hospiar ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zoledric acid hospirin : - if your doctor has told you that you have a kidney problem . - if any of
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose depending on your kidney problem . how zoledic acid hospir works in patients with bone complications due to bone metastases , the recommended amount of infusion given is one millilitre ( ml ) per day . how is zoledoledronic air hospira given ? z
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported with zoledic acid hospir : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness or loosening of a tooth . these could be signs
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ).
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledrine acid contains 4 mg zoledrin acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains 4 vials of zolingronic acid . each pack also contains one vials .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in helping your body fight cancer . they are important for the brain to produce the cells that help you to fight nausea and vomiting . when you feel sick , you may be sick more . rolapit works by stopping the production of these nerve cell cells , which help to prevent nausea and / or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has prescribed varubchy for you . if you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you think any of these apply to you , tell your doctor before taking this medicine . warnings and risks 27 if you suffer from severe liver or kidney problems . if your dose of certain medicines ( e . g . rifampicin ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . it may take up to 2 weeks before your chemotherapy cycle starts . you will usually take varubsy during chemotherapy to reduce the risk of sickness . if you take more varubys than you should if you have taken more medicine than you have been told to , contact your doctor straight away . if possible , show them the pack
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swellingof skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as you may need appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache constipation feeling tired uncommon ( may effect up to1 in 100 people
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubry
what enerzair breezhaler is enerzir inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopreyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to agroup of medicines known as corticosteroids and steroids . corticoplastics reduce the swelling and irritation ( inflammation ) in
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes , high blood sugar , seizures if you drink alcohol if you smoke if you know that you have severe kidney problems if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . always use the medicine exactly where your doctor tells you to . check the box at the end of this leaflet to make sure you have used it correctly . if you use more enerzair breezhaler than you should if your asthma has become worse , or if your symptoms get worse , contact your doctor . how to use enerz air breez inhaler use enerzeair breezy inhaler as described in this leafle . you will
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop taking enerzair breezhaler and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side side effects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , whe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate , 63 microgram of glycopreyronium bromides , 50 microgram glycopyronium and 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram ( 3 . 5 microgram ) of indiacaterol , 58 microgram( 3 .
clopidogrel acino pharma gmbh contains the active ingredient clopidgin which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thromebosis ). clopidineogrelacino pharmae gmbhs is taken to prevent blood clubs ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atheroth
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogel or any of the other ingredients of clopidineogrel agibilise . if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . if this applies to you , do not take the next dose of clapidogl agibbilise . warnings and precautions talk to your doctor or pharmacist before taking clopideogrelacino
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopideogrelacino pharmh per day to be taken orally with or without food . you can take cloclopidoggingrel acine pharma h for as long as your prescription continues to prescribe it . if you take more clopidoogrel agrogrogroggmbh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogel acino pharmaceutical gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmha gmb h looks like and contents of the pack clopideogrel acet
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( which is also a nucleosides analogue reverse transcripttransferase inhibitor [ nrti ]) and tenofovir disoproxil ( which are also known as a nucleositide analogue reverse transcriptase inhibitor or nrtis ). delstrigo can be used in adults and children aged 18 years
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if taking any of them , tell the doctor or nurse that you are taking any or all of the following medicines : carbamazepine , oxcarbazepine or phenobarbital , phenytoin ( medicines used to prevent seizure ) rifampicin and rifapentine ( medicines to treat tuberculosis
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet should not be used for hiv infection . the dose should not exceed 1 tablet a night . if you take certain medicines , e . g . doravirine , please consult your doctor . medicines that may affect your response to this medicine swallow the tablet whole with a glass of water . do not chew , crush or break the tablet . taking this medicine take delstigo at least 12 hours before or at the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain , vomiting wind ( flatulence ) hair loss rash muscle symptoms , pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material : carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and relieves the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . it is important that you also read the package leaflets for antidepressant medicines .
do not use spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can occur . serious complications in these conditions can occur , and your doctor may need to adjust or stop the dose of spravate . if you have a heart problem , poor blood flow
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravat nasal spray is for inhalation use only . the nasal spray device is for use in adults . use in children and adolescents the recommended dose is 1 spray ( 2 sprays ) per kg body weight . there are 3 nasal spray devices : one nasal spray handset is for administration use in infants and children aged 4 months to less than 4 years . spravata is for nasal use in adolescents aged 2 years and older . use this product only if you have
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to light in the mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy , euphoria , feeling agitated , feeling anxious , feeling in the eyes , ears or sense of touch are altered or mimicked irritable panic attacks change in perception 37 feeling ,
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spraydevice . spravata is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . each spray device is sealed in a sealed
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be caused by cancer caused by a change ( mutation ) in a gene called ' melanoma ' ( mpa - roe ). zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) - if symptoms of allergic reactions ( such as swelling of the face , lips or tongue , difficulty breathing , rash , fainting sensation ) occur . warnings and precautions talk to your doctor or pharmacist before using zelberaf . allergic reactions if you experience allergic reactions to zeloraf , stop using zezboraf and contact your doctor immediately . if you have any symptoms of an allergic reaction ( such : swelling ofthe face , lip or tongue ),
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 capsules taken once a day for 8 days . your doctor may increase your dose to 4 capsules once a week for 4 days . if you take more zelboraf than you should if you have taken more capsules than you have been told to , contact your doctor straight away . you may experience side effects , stop your treatment and contact your nearest hospital straight away if you experience any of the following : vomiting if you forget to take zelbaf if you miss a dose of z
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you experience any of the following symptoms : radiation treatment can cause serious side effects . radiation can damage the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if your doctor has any of these symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills (
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any particles in the solution or if the pack is damaged . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veurafenb ). the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelbaf
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ). these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels are formed . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke ,
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( aa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic , ask your doctor for advice . if you have been treated with other products called non - steroidal anti - inflammatory products . if your doctor has told you that you have painful and / or inflammatory conditions of muscles or joints . if any of these apply to you , tell your doctor before taking duoplin . warnings and precautions talk to your doctor or pharmacist before taking this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . swallow the tablet whole with a glass of water . you can take your medicine with or without food . do not crush or chew the tablet . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else accidentally takes your medicine , contact your doctor immediately . if possible , take the tablet pack with you . if a child accidentally takes too
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances , clopidogrel and acetylsalicylic acid (asa ). each 75 mg tablet contains clopridogrel ( as hydrogen sulphate ). each 80 mg tablet also contains acetylSalicylic acids ( as mannitol , macrogol 6000 ), microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil . see section 2 ' duopllin contains hydrogenatedcastor oil ' for further information . the
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists , which work by reducing pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have been previously treated for eye conditions such as glaucoma , ocular hypertension and high pressure in one or both eyes .
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you currently take certain antidepressants . if you previously take any antidepressant medicines , you should tell your doctor . if any of these apply to you , tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . use in the affected eye and eyes wash your hands thoroughly ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . before using the medicine , twist off the cap . hold the bottle with your fingers . tilt the tip of the bottle back . pull down the eyelid with a clean finger and insert a ' pocket ' between the eyelids and the coloured part of the eye . the drop will go
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : - if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . tell your doctor immediately : extreme tiredness and dizziness . the other side effects that have been reported with simbrinza are : - when simbratinza is used in combination with other medicines containing brinzolamide or brimonidine
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should if you accidentally use too much simbrinaza , tell your pharmacist or nurse straight away . you may get infections . if this happens , use a new bottle . do away with the bottle .
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinza and 2 mg of of brimonine tartrate equivalent to 1 . 3 mg of Brimonidine . the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide . purified water contains hydrochlorIC acid and
filgrastim ratiopharm contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in the body called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . filrastim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgrimastim helps to increase the number of white blood cells in your
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgrastaim ratim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitarm . if you have a cough , fever or difficulty breathing , tell your doctor straight away . this may be a sign of a pulmonary disorder . tell your nurse straight away if you get any of these side effects . sickle cell disease 57 if you feel left upper abdominal pain or pain at the tip of your shoulder , as
how much filgrastim ratiopharm is given the amount of filgrastaim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasteim ratim ratilarm treatment . filgrateim ratiotopharm will be given to you in a hospital or clinic under the supervision of a doctor experienced in the treatment of chemotherapy . the recommended dose is 0 . 5 mg per kilogram body weight given once every 60 days . your doctor will decide how many days you should receive your treatment . the usual dose is 14 mg per kg body weight . some disease types
you should not be given filgrastim ratiopharm if you have sickle cell disease 57 you should not receive filgratim ratisopharm : if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will do regular blood tests before and during treatment with filgrasteim ratim ratiotarm . this is to check the number of neutrophils ( a type of white blood cells ) in your blood . your blood will be tested before and after treatment with this medicine . other medicines
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopharms if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrgrastime . filgrasteim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg of filmgrastrim in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one pre -filled syringe containing 48 mg of the active ingredient filgrateim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial ac
what riluzole zentiva is riluxole zenta contains a substance called rilusole which belongs to a group of medicines called cytokines , which stimulate the nervous system to work more effectively . what rilzole zENTiva is used for rilizole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells responsible for sending messages to muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurones disease may also be caused by too much glutamate ( a
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor before taking rilzole zenta . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have anyiver problems . yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( which may be a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth once a day , preferably at the same time each day . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swallowers some
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . this is seen in a blood sample . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor will do regular blood tests before and during treatment
what riluzole zentiva contains the active substance is rilusole . the other ingredients are anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white , round and engraved with the code ' 50 ' on one side . riluxole zENTiva is available in packs containing 202 tablets . rilanuzole zinc
the active ingredient in emgality is galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ), which is involved in migraine . increased levels of cgrm can lead to an increased risk of migraine . emgally is used to treat migraine in adults , adolescents and children aged 4 years and older who have at least one previous migraine . migraines with emgali have been reported in patients with at least two previous migraine administrations . the frequency of migraine headache is not known . emergality is used in adults to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . you should see your doctor immediately if you notice such signs or possible side effects . see section 4 . children and adolescents emgale is not recommended for children and teenagers under 18 years of age . other medicines and emgali tell your doctor or pharmacist if you be taking , have
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg of emgally given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or in a hospital setting . after proper training , you should receive the full 240 mg dose . do not take a double dose to make up for a forgotten dose . if you have any further questions on the use of emegality , ask your doctor , pharmacist or nurse . if possible , ask you doctor , nurse or pharmacy
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product may be stored for up to 7 days at room temperature ( up to 30 ) in the original package . do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colourless solution is clear to slightly yellow . the syringe is supplied in single - dose pen packs of 1 , 2 , 3 or multipacks comprising
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and clogged with blood clots . it can be given alone or with medicines obtained prior to a stem cell transplantation . defibroide works by helping the blood vessel to open and close , so that the blood clasts can be removed . your doctor has prescribed this medicine for you .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor or nurse before using this medicine . warnings and measures talk to your doctor , pharmacist or nurse if you : have bleeding or heavy bleeding if you need a blood transfusion or surgery if you suffer from problems with blood circulation ( a constant blood pressure ) if your doctor has told you that you have a
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given into one of your veins as an ' intravenous infusion ' ( drip ). you will be monitored during this treatment for 21 days until your symptoms improve . if you are more than 18 years old , your doctor may decide to give you defitelfio by another doctor or nurse . if necessary , you may be given a double dose to make up for a forgotten dose . if any of the above apply to you , tell your doctor or pharmacist before you are given this medicine . if
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting blood bleeding in one or more of the lungs bleeding in blood in the urine and in the mouth bleeding in any part of your body including the skin coagulopathy ( disturbance in blood clotting
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use definitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibroide . after dilution , each ml solution provides 80 mg of the active ingredient in defibritio . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless solution for infusion . it is supplied in a 10
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver , caused by the hepatitis c virus . this medicine stops the hepatitisc virus from multiplying in your body . it also prevents the virus from spreading to other parts of your blood . daklinz is used in combination with other medicines to treat the hepatitis k infection . the other medicines that you will be taking with daklanza are : - oral , oral , or combination with a tablet . daclinza is taken with other medicine to treat or prevent hepatitis c infection . your
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with any of your following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to help prevent allergic and inflammatory diseases ) medicines containing st . john ' s wort
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this twice a day to avoid unpleasant taste . your doctor may tell you to take dakinza with some other medicines . if you take more daklatinza than you should if you have taken more dailinza than your doctor tells you to , contact your doctor . if possible , take your daily dose of taklinz at the same time each
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dailinza in combination of sofosebuvir and ribavir the following other side effects are reported : common ( likely to affect up in every
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack 30 mg
proquad is a vaccine that helps protect against measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s own immune system ( the body ´ s natural defences ) will produce antibodies against the measles , rubles , rubell , and varicelluses . the antibodies help protect against diseases caused by these viruses . proquad is used in adults and children 9 years of age and older . national vaccination schedules are available to protect against all types of measles caused by live viruses . measles , measles , papella , rubello , chicken po
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have been given neomycin if you suffer from a blood disorder or type of cancer that affects the immune system , treatment with medications that suppress the immunesystem , including low - dose corticosteroid therapy , asthma or replacement therapy if you currently have a weakened immune system due to a disease ( including aids ) that suppresses congenital or hereditary immunodeficiency ( immune competence ) if any of these apply to
proquad is given by injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections should not be given into the upper muscle or thigh area or into the arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not go into the skin . bleeding may occur in the muscle . proquad should not enter into the blood vessel . pro quad is given as an injection into a blood vessel ( intravenously ). proquad is recommended for use in infants and children from 9 months of age and adolescents from 12 years of age . it is not recommended for children from nine
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side effect that have occurred with pro quad include : very common ( may affects more than 1 in
what proquad contains the active substances are : measles virus1 , edmonston strain , equivalent to 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , corresponding to 4 . 30 mg rubella virus2 , strain , 3 .00 mg varicella virus3 , merck strain , similar to 3. 99 mg mrc . the other ingredients are : tissue culture : plaque - forming units ( mrc ), 1 , chickembryo cells , fibroblasts ( mcc ), powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e
jylamvo is a substance that is absorbed into the body and is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own immune system to reduce the inflammatory effect jylamv is used for the following conditions : - rheumatic and skin diseases : active rheumatoid arthritis ( where the muscles are damaged ) and polyarthritic forms of the joints in severe juvenile idiopathic arthritis ( jia ) in children and adolescents ( 3 years of age and older ) who have not previously used non - steroidal anti - inflammatory drugs (
do not use jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have a severe kidney impairment - if the doctor has prescribed jylimvo - you have ever had a liver impairment - you suffer from blood disorders called bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 - if any of these apply to you , tell your doctor before using jylervo - your doctor may want to monitor you more closely - if , in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will recommend the treatment that is right for you . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis jylimvo is used as a long - term treatment . jrylamvo is also used for the treatment of rheumatic and skin diseases ( jia ), psorism and psoriatics in adults . your physician will prescribe jylemvo
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching , especially affecting your whole body . other side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or t
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect the medicine from accidental spillage . store in a refrigerator ( 2 - 8 ). do not freeze . store the vial in the original package in order to protect from light . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate (( e218 )), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl paraahydrobenzoates and sodium methyl paraahhydrobenzate "). what jyamelvo
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help adults and children with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this means that it helps to lower the amount of air that gets
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has prescribed enurex breez inhaler . - tell your doctor if you have an eye problem called narrow - angle glaucoma . - you have difficulty passing urine . treatment with enureuv breezer should be stopped immediately if you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine is for inhalation use . you should use this for 24 hours at 75 to 75 ºc . do not use this product if you notice that the capsules are not clear or have particles in them . how to use this medicinal product this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine . the medicine is a clear inhalation powder . the capsules should be swallowed whole with water .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). other side effects include some side effect not known ( frequency cannot be estimated from the available data ) other sideeffects include frequency not known :
what enurev breezhaler contains the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycopirroniumbromide equivalent to 50 microgram of glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium per inhalation dose . the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurelv breezer 44 microlitre inhal
what riximyo is riximusimyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in the body called a white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , it stops the cell from growing and dividing . what rixima is used for riximalyo is used to treat adults with two different types of lymphoma : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixamyo . rix
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may lower your dose . riximeyo is given as a drip ( intra - venous infusion ). medicines given before each rixima administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will determine the dose you need and will adjust your dose depending on how you respond to
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets ,
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg per ml . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it
topotecan actavis contains the active substance topotecin . topotecaan actis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotan actalis treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ if your blood cell counts are too low . your doctor may decide to reduce your dose of topotican actis . if you have any kidney problems . your dose should not be increased . talk to a doctor or nurse before using this medicine . warnings and risks talk to the doctor or hospital pharmacist if you think any of these apply to you , or if you
your doctor will determine the dose of topotecan actavis you will receive based on the disease and on results of blood tests carried out before treatment . the recommended dose for treatment of adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer : 0 . 75 mg per sq metre of surface area , for 3 days . your doctor will decide on the dose that is right for you . this dose cycle will also be repeated each three weeks for cervical cancers . for the treatment of cervical cancer , the recommended starting dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough and fever . this severe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 to 9 ). from a microbiological point of view , the drug product solution should be used immediately . dilution in solutions
what topotecan actavis contains the active substance is topotecaan . each vial contains 1 mg or 4 mg topototecin ( as hydrochloride ). after reconstitution 1 ml contains 1mg topotan . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotican actis looks like and contents of the pack topottecan actalis is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , with a protective sleeve .
the active substance of rivastigmine hexal is rivasterigmine . rivastersigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasta works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholinestransferase . by blocking these
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ) that was not well controlled with rivustigmine . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking this medicine . - if any patient has : irregular or slow heartbeat -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also adjust your dose depending on your weight . you should take this medication every day until your doctor tells you otherwise . if you have not taken rivasta hexal for more than three days , do not take the next dose until you
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below are very common ( may affect more than 1 in 10 people ). feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may effect up to1 in 100 people
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivasterigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivasta hexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each riastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each ritastigme hex
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be used alone or in combination with a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking the action , these proteins can help to kill high amounts in cancer cells . cabometrix is used in adults .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you have high blood pressure , have an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recent had significant bleeding from surgery within the last month , have had surgical procedures , dental surgery , have inflammatory bowel disease , crohn ' s disease , ulcerative colitis , diverticulitis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose depending on how you respond to your treatment . this is because you may experience serious side effects . your treatment may need to be slowed down or stopped . cabometyx is for oral use . swallow the tablet whole with a glass of water . you can take cabometometyx with or without food . you may take cabostyx with food or between meals . it is
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor or nurse straight away if your side effects become severe or persistent . tell your healthcare professional straight away : if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine ,
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s )- malate equivalent to 20 mg cabozandinib . cabostyx 40 mg : one tablet contains Cabozanthinib (s )- Malate equivalent of 40 mg cabzantinab . cabobometyx 60 mg : the active substance is cabozutinib_( s ) - malate similar to 60 mg cabazantininib the other ingredients are microcrystalline cellulose , lactose anhydrous
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexed hospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . when pemetreed hospiera is given to treat lung cancer , your disease will be treated at once and
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetreted hospiral , your doctor will check before each infusion that your blood is being
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will use this body surface area to work for you . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetresed hospire will be given to your doctor by infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( common ). if you are having pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you develop skin rash ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at refrigerated temperature . the reconstitution solution should be used immediately . parenteral medicines : if there is discolouration prior to administration , this medicine should be administered immediately . any unused solution should
what pemetrexed hospira contains the active substance is pemetreed . pemetrion hospira 100 mg : each vial contains 100 mg of pemetretted ( as pemetroxed disodium hemipentahydrate ). pemetirion hospirite 500 mg : one vial of 500 mg contains 500 mg of dispemetrexED ( as dispemetroxhed disodium emipenthydrate . pemrexedospira 1 , 000 mg : the active ingredient is pemphigus . further dilution by a healthcare professional is required prior to administration . the
ganfort contains two active substances called bimatoprost and timolol . both help to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work together by blocking a prostaglandin analogue called timolole . timololed belongs to medicines called beta - blockers . ganfort is a clear , watery liquid that is injected into the eye by your eye . gansfort is used in adults , adolescents and children aged one year and above . it is used to treat high pressure in an eye in adults with glaucoma . g
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis - if he / she has severe lung disease - if the child has wheeziness or difficulty in breathing - if they have long - standing cough - if his / her child has heart problems such low heart rate or heart block - if their child has had heart failure warnings and precautions talk to your doctor or pharmacist before using
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the mirror . twist the neck , about 5 . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid , which is covered by a small pocket . 3 . gently squeeze the bottle until the drops are in your eye . during treatment , 4 . remove the lid from the eye . gently press down on the eye with a finger until the drop is in the eye , then gently squeeze again . 5 . gently pull down the front
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause the following side effects when given with ganart ( multi - dose or single - dose ) alone : very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the solution in the original package in order to protect from light . do away with ganf after 4 weeks . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ). - the other ingredients are timolol 5 mg / l ( corresponding to timolole maleate ) and 6 . 8 mg / vial ( as benzalkonium chloride , a preservative ). - ingredients in the solvent are sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack ganst is a clear to slightly yellow , round
gefitinib mylan contains the active substance gefitinib . this protein is designed to recognise and kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitalinib melan if : you have any other lung problems . some lung problems may be serious and you should stop taking gifitin ib mylan . you have problems with your liver . gefinib is not recommended for use in children under 18 years of age . other medicines and gefnitinib tell your doctor if you take , have recently taken or might
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you may take antacids on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). take the tablets at least 1 hour before or 1 hour after food . gefinib melan can be taken with or just after food if you have trouble swallowing the tablet . if you take any other liquids , contact your doctor . the total recommended dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs ( called ' interstitial lung disease '). uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions which affect any part of
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what gefitoninib melan looks like and contents of
reblozyl contains the active substance luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) and need red blood infusion . reblozey is used in adults to treat anaemia in patients with mds who cannot receive red bloodcell transfusions ( erythropoietin therapies ) and in children with beta - thalassaemia . thalAssaemia is a blood
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have thalassaemia ( a condition where a part of the spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot and you are not taking preventive measures ( e . g . medicines to prevent a blood clot ) if any of these apply to you (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the injections should be given every three weeks . the recommended dose is 1 . 0 mg / kg of body weight . your dose may be adjusted by your doctor depending on your blood pressure . use in children and adolescents rebluzyl is used in the treatment of myelodysplastic syndromes . the maximum single dose is : 1 . 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to a maximum of 25 hours and then refrigerated for up 24 hours at 2 8 . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg luspaterscept . after reconstitution , each mlof solution contains 50 mg of luspisercept . the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . reblizyl 25 mg / 75 mg solution for injection in v
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer and slowing down the growth and spread of cancer cells by blocking new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked well enough .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda . high blood pressure tell your doctor if you have any problems with your blood pressure . fotiva may cause your blood to rise , especially if you take a medicine . fotalda may cause problems with the way your blood work
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days ( 7 days ) followed by 1 day off ( 1 day apart ) for capsules in the morning and 4 days off ( 2 - 8 days ). fotiva should be taken every day with food . if you experience unacceptable side effects or severe side effects , stop taking fotiveda therapy and contact your doctor . the usual starting dose of the fotvda is 890 mg once daily for 21 day (
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension is not usually treated with a medicine to treat your high blood blood pressure . if you take more fotvda than
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tivuzanib ( as tiv ozanib hydrochloride monohydrate ). each tablet of 890mg contains tivzanib in the form of mannitol and magnesium stearate . the other ingredients are gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake ( e133 ), shellac , propyleneglycol
what stribild is stribil contains two active substances : elvitegravir ( an antiretroviral medicine called an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine ( an antiviral medicine known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antipirtrovir medicine known also as a nucleotide reverse transcriptases inhibitor ) stribald is given as a single tablet regimen for the treatment of human immunod
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofovegravira disoprocessil . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have alfuzosin ( an enlarged prostate gland ), amiodarone , quinidine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 years of age and older : the recommended dose is 35 mg taken once daily by mouth . your doctor may change the dose of your medicine or stop the treatment if you take medicines containing oral supplements ( such as antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ). take the tablets at least 4 hours before or 4 hours after taking stribild . if you have any further questions on the use of stribald , ask your doctor ,
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects are caused by stribild or by the hick disease itself . serious side effects tell your doctor immediately lactic acidosis ( excess lacticacid in the blood ) is a
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtritabine , 245 mg tenofovegravirus disoprocessil and 300 mg ten ofovir dissoproxel fumarate . each tablet contains 136 mg tenorovir . the other ingredients are : tablet core : croscarmellose sodium , hydroxypropyl
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa is not recommended for use in elderly patients with dementia because it may have serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be swallowed with water . zchyprexa can be taken with or without food . the dose may be increased from 5 mg to 20 mg once your symptoms improve . swallow the tablets whole with a glass of water . do not chew or crush the tablets . zzyprexa may be taken in combination with food . swallow your zypxa tablets whole . do this with a drink of water or other non - alcoholic drink . you can take your tablets with or just after
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . zyprexa may pose a risk to the environment . do this by asking your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are marked with the following symbols : - zypi 2 . 3 mg , 10mg , 7 . 75 mg and 10
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that attaches to a target in the body . this is another protein that is involved in the process of causing bone loss in patients with osteoporosis . treatment with prolia makes bone stronger , and makes it easier for bone to break . this helps to reduce the amount of oestrogen that your body makes . as bones get older , the level of oesterrogen goes down . this makes bones thinner and fragile . osteopORosis is caused by the lack of female sex hormones , such as testosterone . when osteop
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think you may have a skin infection , symptoms include a swollen , red area of skin ( usually in the leg ), which feels hot and tender . if this happens , tell your doctor . if any of these apply to you , tell the doctor straight away . if your doctor suspects that you have cellulitis , symptoms may include fever
what prolia is prolia contains one pre - filled syringe ( 60 ml ) that should be injected every 6 weeks . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia with or without stickers . you may also inject prolalia with calcium and vitamin d supplements . how prolia works prolia can be given by injection or by infusion . it can be administered to you at any time of the day , including at the same time each week . it may take up to 6 weeks for the last injection . if you use
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia can cause skin infections ( cellulitis ). if you experience any of these symptoms while taking prolia , you should contact your doctor immediately : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms may include fever . - prolia may cause pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), which may be signs of bone damage in the jaw (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , you may remove the cap from the vials and store it at room temperature ( not above 25 ) for a single period of maximum 30 days . do this once a month . do away with the cap and the
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( corresponding to 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard . pack size of one .
what ambirix is ambirrix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by faeces , serum or saliva . symptoms are usually mild to moderate . in 3 to 6 weeks , infection may occur . you may feel sick , have a fever , aches and pains , become very tired , have dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms vary from
do not use ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or nurse before using ambirx if you : have ever had hepatitis a or hepatitis b diseases . if your child has a severe infection with a high temperature . the vaccine should be given at the same time as a minor
your doctor or nurse will give you ambirix by injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . the second injection will usually be given between 6 and 12 months after the first . your doctor may decide to give you extra doses to prevent future booster dosing . if you miss an appointment to have two injections , make another one as soon as possible . if it is more than six months since the last dose , you will be told when to
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to 1 . 5 mg of hepatitis b surface antigen ). 20 microgram s of the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky
xsero is a meningococcal group b vaccine . bexseroe is a type of vaccine that contains the bacteria neisseria meningitidis group b . be xsero will be given to adults and children from 2 years of age and older who have a disease caused by the neisseritidis type b bacteria . these bacteria are responsible for many types of infections , including meningitis and inflammation of the brain and spinal cord . they also cause sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex sero if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . vaccination of patients with haemophilia a if you have any other problem that may prevent your blood from clotting properly . you should be treated with blood thinners ( anticoagulants ) as part of treatment with the immune system ( eculizumab ). if you
your doctor or nurse will give you bexsero at the following dose : the recommended dose is 5 micrograms injected into the muscle of the thigh or upper arm . injections will be given at least 2 weeks apart . the recommended doses are 5 micrograms given at the same time each week . after three injections , the vaccine may be administered as an additional injection ( booster ). the first injection will be administered at least 1 month apart . if the interval between injections is less than 2 months , your doctor will administer a booster . children and adolescents from 12 months of age and above 15 years of age : the vaccine will be
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injection area . other side effects may occur with this vaccine : common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around the injectionsite , severe injection site
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 , 2 and 3 50 microgna recombinant neoisseria meeningitidis ( group b fhbp fusion protein ) 1 , 3 , and 50 micromole / ml recombinant non - recombinant noisseria womeningitidas group b fehbp infusion protein 1, 2 , and 3 , 50 micromg / ml excipients produced
what nitisinone mdk is nitisinfone is a medicine used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . in this disease your body does not break down the amino acid tyrosine ( amino acids are substances that are naturally present in our body ). nitisinusone works by breaking down tyrosrine and the harmful substances it contains . this medicine helps to remove tyrosate from your body by lowering the amount of low tyrosin and phenylalanine ( another amino acid ).
do not take nitisinone mdk - if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdks may affect the eyes . during nitisinfone treatment , red eyes may occur . if you notice red eyes , tell your doctor immediately . your doctor may recommend an eye examination . if any of these apply to you , tell the doctor . eye problems due to inadequate dietary control may occur ( see section 4 ). your doctor will monitor you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once daily . the dose may be increased to 20 capsules once daily depending on the response of the patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister once you have reached a temperature not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitisinnone md k 2 mg : each hard capsule contains 2 mg nitisine . nisinonemdk 5 mg : one hard capsule releases 5 mg nisine . each hard capsules releases 10 mg nitesinone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze and water for injections . what nitisinfone mdks looks like and contents of the pack nitisinsone mdky capsules are 15 . 7 mm long , hard gelatin capsules imprinted
what docetaxel accord is docetxel accord contains the active substance docetacel . docetaceel belongs to the group of anti - cancer medicines called taxoids . docelaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer in adults , docetailel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine .
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may occur . if you experience fever or infections , tell your doctor immediately . abdominal pain , tenderness , diarr
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken at regular intervals to check your generalcondition . in particular , docetAXel accord
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be higher when docetxel is given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the vial should be used immediately after dilution . the medicine should be transferred from the infusion bag to the infusion vial within 6 hours of dilution ( see section 25 ). for infusion , the infusion solution should be stored in non - pvc bags for 48 hours at 2 to 8 . do
what docetaxel accord contains - the active substance is docetxel . one ml of concentrate for solution for infusion contains 20 mg docetel . 1 ml of the concentrate contains 20mg docetixel . 4 ml of solution for concentrate contains 80 mg docelaxel . 8 ml of solvent contains 160 mg docnetaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol "), citric acid anhydrated ( see " docel accord contain ethanol "). what docetAXel accord looks like and contents of the
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product is used to treat impulsive and hyperactive adults . this medication is used in adults to treat ' attention deficit hyperactivity disorder ' ( adhd ) when current stimulant medication is not controlling adhd symptoms . the medicine is used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used 38 in adults with adhd . adhd is not a cure for adhd ; it is a treatment program that is intended for adults
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunive if you have low or high blood pressure . heart problems tell your doctor if you know you have heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . tell your physician if you suffer from any other psychiatric conditions , including withdrawal symptoms . increased heart rate and high bloodpressure have been reported in patients taking this medicine . your doctor may need to adjust the dose of this medication to
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on your response to treatment . the starting dose is 0 . 05 mg / kg bodyweight once daily ( for example , 0 . 12 mg / m2 of bodyweight ). your doctor may increase your dose depending on how you respond to treatment and on how well your body responds
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should continue to take your medicine as usual . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ), feeling faint and loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if you experience any of these side effects during treatment ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blister pack . do away with the tablets once you have opened them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg guanFacine . each 2 mg prolonged -release tablet contains guanfuine hydro chloride . each 3 mg prolonged release tablet delivers guanjuine hydroxychloride and each 4 mg prolonged prolonged - releases tablet delivers the full amount of guanaguine . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a , crospovidon type a, microcry
ecalta contains the active substance anidulafungin . it is used to treat adults and children from 1 to 18 years old with fungal infection of the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida that are cut off and grown in the laboratory . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections from spreading and destroying fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra . your doctor will check your liver function . if you have liver problems , your doctor may decide to delay your treatment with anaesthetics . your treatment may need to be slowed down or stopped . ecaltfa can cause an allergic reaction , such as itching , wheezing , or blotchy skin . signs of an
the treatment will be started by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a day . the dose is 1 hour before breakfast . adults ( aged 18 years and over ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a day , with a maximum dose of 1 . 5 mg / day . this dose is based on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will be calculated by your doctor based on how much ecaltva you have received . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ecalta : potentially life - threatening allergic reactions , including difficulty breathing or wheezing , or an existing rash . ecaltra can cause serious side effects such as convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing or coughing , or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . if the infusion solution is not used within 25 hours it should be stored in a refrigerated unit (
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in patients 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium ( e . g . any of the other ingredients of this medicine listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , whe
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia . adynov is used for treatment of bleeding . adnovi is used as the replacement therapy for adynocov . adenovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adynova is 40 mg once a day . your doctor may increase your dose to 50 mg once daily for 2 weeks . prevention and treatment of blood and bleeding the dose of adsynovi depends on your
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is needed . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see section
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is stored at a room temperature not above 30 and cannot be kept refrigerated for a longer period than 3 days , or if
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are produced by the ovaries and are responsible for the development of many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have : a large tumour in the uterus ( ovaries , breasts , pituitary gland or hypothalamus ) enlarged ovaries or cysts on your ovaries polycystic ovarian disease ( bleeding from the vagina ) an early menopause with malformations of the sexual organs ( see section " pregnancy and breast - feeding ") fibroids of the uterus . pregnancy
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will also give you anti - müllerian hormone to stimulate your ovaries to produce stimulation with gonadotropins in your blood . your dose will depend on your body weight . your physician will take a blood sample during the last 12 months to check how well the medicine is working . the dose will vary depending on your condition and how you respond to treatment . your bodyweight will be checked at regular intervals during treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported in women receiving this medicine . there may be a high level of activity in the ovaries . ovarian hyperstimulation syndrome ( symptoms include pain , discomfort , swelling of the abdomen ), nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , contact your doctor immediately . a side effect that may affect up to 1 in 10 women is headache . nausea . ovarianhyperstimulation sensation ( symptoms includes pelvic pain and discomfort , ovarian
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 for a single period of up to 3 months . after this period , the product should be used within 3 months or disposed of . however , if not used within this period of 3 months , the solution should be stored at room temperature ( up to 28 ) and not above 25 . do away with the treatment
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient of folliotropin delta in each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptoe contains flutic asone fureate and 92 mg vilancerol . the 22 mg / 22 mg inhalation contains flitantasonefuroate 184 mg vilterol and 22 mg respectively . the 92 / 22 / 22 dose is based on the following categories : chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) whose asthma is not controlled with 184 mg / 23 mg inhalations . asthma in
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor determines that you have moderate or severe liver disease . the lower strength of revintlly ellipta 92 / 22 mg may be harmful to you . if any of your conditions apply to you , tell the doctor straightaway .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhaler of fluticasone furoate and 22 mg vilanterol ). for severe asthma , the higher strength inhaler is one spray of flitantasonefuroate 22 mg twice a night ( one spray in the morning and one in the evening ), with or without vilancerol . copd the recommended starting dose for copd is one and a half inhalations twice a
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), becoming very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties if you have immediate breathing problems while taking revinty
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol ( as trifenatate ). each 184 microgramS inhalation provides 184 microliters of flritasonefuroate , 22 micrometre of Vilanteriol ( astrifenate ). the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is sodium "), magnesium stearate .
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcript enzyme inhibitor ( acei ). these active substances are all given together with antiretroviral medicines to reduce the production of an enzyme ( reverse transcriptasing ) that the virus needs . atriplas is a treatment for human immunos
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) may occur during the first few hours after taking atriblea . if you take more atriplea than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with you . atrippla can be
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavairenz ( 200 mg emtritabine ) and 245 mg tenofvir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atribla contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophins releasing hormone ( gnrh ), which is produced by the body . release of gonadotroprophins is a naturally occurring hormone that stimulates follicle stimulating hormone ( fsh ). gonadots play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells straight away . they are then grown in
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadoteh - like hormone ( agnrh analogue ). - have a moderate or severe kidney or liver disease . - are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions may be signs of an active allergic condition . your doctor will do additional monitoring during treatment . allergic reactions if you experience allergic reactions ( generalised
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), or corifollitropin on day 2 or day 3 of each cycle . orgdalutran will be injected under the skin ( subcutaneously ) on days 5 and 6 of each cycles . orglutran can be used with or without fsh . the preparations
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after about 4 weeks . uncommon ( may affect up to 1 in 100 people ) is headache , nausea , malaise . rare ( may affects up to1 in 10 , 000 people ) allergic reactions are rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat with difficulty in breathing or swallowing ( angioedema or anaphylaxis )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , solvent - free solutions . do away with any unused syringe . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide ( for acetic acids ). what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution for injection . the solution is clear and colourless . it is intended for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , it stops the cell from growing and dividing . what blitzima used for blitzima has been given to you by your doctor to treat : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue that affects the immune system . it affects a type a of white blood type
do not use blitzima - if you are allergic to rituximab , other proteins that are similar to ritonuximib or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has a severe active infection - if he / she has a weak immune system - if the child has severe heart failure or severe uncontrolled heart disease - if any of these apply to your child ( see section 4 ). warnings and precautions talk to your doctor or pharmacist before using blitzima if your baby has : granulomatosis , polyangiitis , microscopic polyangioniitis or
how blitzima is given your doctor will decide how much blitzima you will receive and how often you will need this treatment . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may lower your dose . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your doctor or nurse will decide on the most appropriate dose for you . duration of your
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials , each containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain . this target is found on the surface of the body and causes the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra prevents the damage to the cartilage and bone in the joints caused by the disease . roacticemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease where previous therapies did not work well enough or did not reduce
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor or nurse before the infusion with roactemnra if any of your sudden signs of allergic reactions ( such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash ) occur during or after the infusion . infection tell your doctor immediately if you feel unwell . roactemara may affect your body ' s ability to fight
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will supervise the intravenous infusion . your doctor will decide on the treatment that you need . the recommended dose of roacterera is 8 mg / kg body weight . the usual dose is 4 mg /kg body weight once a day . the dose may be increased or decreased by up to 8 mg per kg bodyweight once a week . the maximum recommended dose is 30 mg / kilograms body weight twice a week for up to 12 weeks . the daily dose may increase or decrease by up or
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the following frequencies ( see section 3 ): stop taking roactamra and see a doctor straight away : serious side effects ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , especially in the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur in up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack roactremra
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . onbrez bronzhalhaler is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles relax , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out of the lungs when you breathe in .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer breezer : - if : - you have heart problems - you suffer from epilepsy - you are suffering from thyroid gland problems ( thyrotoxicosis ) - you drink alcohol excessively - you smoke - you develop diabetes during treatment with on
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) twice a week . your doctor may adjust the dose depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . onbrez breezhaler is available as an inhaler and capsules ( in blisters ) containing the medicine are available as inhalation powder . the onbrex breez inhaler contains the medicine as inhal inhalationpowder .
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalzer 300 microgram inhaler 300 microlitre inhaler includes 300 micrometres of of indiacaterol as indiacatholmaleate . - the ingredients are made of lactoseand the capsule contains gelatin . what onbreez breezeler looks like and contents of the pack
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopideogrel clots ( thrombi ) are clumpings to hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloprid
do not take clopidogrel hcs - if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). - if a medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease is a problem . if any of these apply to you , tell your doctor before taking clopridogrel clcs . warnings and precautions take special care with clopidineogrel ccs if any other conditions increase the risk of bleeding such : - if your child has a medicalcondition that puts you at risk of internal
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are ( see section 2 ' clopidaogrel hexcs contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil in the tablet core ; film coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron
febcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been able to fight with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had other antibiotics ( e . g . cephalosporins ). if your doctor has told you that you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this happens , tell your doctor straight away . if you experience severe skin peeling and
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours . it may take up to 2 weeks for fetcroja treatment to work . your doctor will check you for infection . if your infection is not well controlled , your doctor may treat you with a lower dose . you should not experience any pain during the fetcroJA infusion into a separate vein . if you have kidney problems tell your doctor . if kidney problems are not well treated , your dose of fetcroj may be reduced . if this happens , your next dose of fetcroja will be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines given to slow bowel movement may be added to the mix . other side effects if you get any of these side effects : very common ( may affect more
what fetcroja contains - the active substance is cefiderocol sulfate toylate . each vial contains 1 mg cefingerocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatinous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is a type of protein that recognises and attaches to lymphoma tumour cell cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness , and visual disturbances . if you experience any of these symptoms , stop using depocyte and contact your doctor immediately . taking any dexamethasone tablets at the same time may increase the risk of unwanted effects . if your side effects are severe ,
treatment of cancer in the lumber sac will be overseen by a doctor experienced in the use of depocyte . depocyte will be given to you by a qualified healthcare professional . the recommended dose is one vial of 1 mg or 5 mg of dexamethasone 5 mg / ml . each depocyte dose will be monitored by your doctor to detect any side effects . the dose of depocytes will depend on the body surface area ( temperature ) and on the quantity of product being withdrawn . the usual dose is 22 mg / kg or 30 mg / m2 . after withdrawing depocyte from the vial , proper precautions should be
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very common : affects 1 or 10 users of 10 users per 10 , not known ( frequency cannot be estimated from the available data ) very rare : affects less than 1 users in 10 , 000 not known : frequency cannot been estimated from available data very common adverse events have been
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this if you notice that the solution is discoloured or shows signs of tampering . do away with the vials and dispose of them . do do not throw away any medicines via wastewater or household waste . ask your pharmacist
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarbine . each vial of depocyte 5 ml solution contains 50 mg cytabine ( as cholesterol , triolein ). - the other ingredients are dioleoylphosphatidylcholine , dipalmitoylophosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied as a 5 ml clear glass vial with a single injection . depocyte can
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacatersol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids ( steroids ). corticoplastics reduce the swelling and irritation ( inflammation ) in the smaller airways , making breathing problems worse . cort
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be allergic . - if any of these apply to you , tell your doctor before using bemist breez inhaler . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - had diabetes - have high blood sugar - have seizures - have a low level of potassium
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should use the medicine every day , at the same time of day . this will help control your asthma and reduce your symptoms . do not change the dose of bemist breez inhaler without your doctor ' s advice . be mrist breezezhalzer is for inhalation use only . how to use bemrid breezer is for oral use . you will need an inhaler and capsules to use the medicinal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of your tongue , the lips , face or throat ( angioedema ). other side effects other sideeffects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation contains 173 microgram indacate . each capsule contains 150 microgram of indacatesol and 80 microgram mometsone furuate . the mouthpiece of the inhaler contains 125 micrograms of indiacaterol and 62 . 75 microgrammometasony furoates . beemrist breezy inhaler 127 .
zyllt contains clopidogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clubs ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). zllt is also taken to reduce the risk of
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before taking zylltt , tell your doctor if any of these apply to you . if any one of these applies to you , tell the doctor before taking the medicine . if your doctor thinks that you are at an increased risk of bleeding such a medicalcondition that puts you at risk of internal bleeding ( such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended starting
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 under ' zylltic contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllts looks like and contents
what lamivudine teva is lamivudaine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamivuxine tea is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic ") infection can lead to liver damage . lamlivudineteva helps to protect the liver in patients with compensated liver disease . treatment with lamividine tev reduces the amount of
do not take lamivudine teva - if you are allergic to lamivu or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuvudine teava may be taken with other similar medicines which can cause serious side effects . - if your doctor has told you that you have liver disease , such as hepatitis c . - you are overweight . your doctor will do blood tests before you start your medication . see section 4 for more information . warnings and risks talk to your doctor , pharmacist or nurse before taking lamividine tevas . if your hepatitis is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor will prescribe the best dose for you . your dose will depend on your condition and on the condition of your doctor lamivudine teva is taken orally with or without food . your physician will tell you how many tablets of lamivuda teva to take . if you have problems with your kidneys , your doctor may prescribe lamivuine either alone or with another medicine . the usual dose of lamvudine for treating hiv infection is
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b are listed below . the side effects that have been observed during lamivuine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these are signs that the liver is not working properly . these may be due to the build - up of enzymes in the muscles
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivduine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by interfering with the natural hormone erythropoietin . erythroietin works by helping your kidneys to produce more red bloodcells . it is also given to you by your doctor to increase the number of red blood cell in your blood . darbepoetin alfa is used to treat chronic renal failure . symptomatic anaemia can be
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nesp ( darbepoetin alfa ) or r - huepo . warnings and precautions talk to your doctor before using nespos if you suffer from high bloodpressure or are using medicines for sickle cell anaemia . epileptic fits ( seizures ), convulsions or fits have been reported in patients with seizures . if your doctor has liver disease , or if you take drugs to treat anaemia , tell your doctor . if any of the above apply to you , tell the doctor before
your doctor will carry out blood tests before you start nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 12 hours using the pre - filled syringe . this is given into a vein ( intravenous ). if you have chronic renal failure , you will be given a single injection under the skin or into a veins ( intravenously ). how much nespos you will receive your doctor may decide to change the dose or how often you will have nesp . the dose will depend on your body weight .
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare ( may affects up to1 in 10 , 000 , 000 patients ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep nespos in the original package in order to protect from light . before you start using nespen , remove your syringe from the refrigerator and use it within 30 minutes . after this , use it for 7 days . do this every time you start to use nnepo . medicines should not be disposed of via
what nespo contains the active substance is darbepoetin alfa . each ml of solution contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu of the active substances darbiepoetein ala . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e470b ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack nespi is a clear , colourless to slightly
macugen is a solution for use in the eye called pegaptanib . this medicine is used to reduce abnormal formation of new blood vessels in theeye . macugen is used for the treatment of adults with macular degeneration . in this disease , vision loss is caused by damage to a part of the retina ( macula ) that lines the front part of your eye . macula is the thin layer of the macula that lines your eye , amd . abnormal blood vessels grow in the retina and become larger , blocking the macular ' s ability to pump blood through them . these new blood structures can bleed or leak fluid
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection , including bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these occur , tell your doctor straight away . if the following symptoms occur , contact your eye doctor immediately : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased
mugen will be given to you by a doctor or nurse who is experienced in giving injections of macugen . macugen is given as a single injection into the eye ( intraocular ) every 6 to 9 weeks . the injection will be injected into the vitreous part of the eye . your doctor will decide how much macugen you need and how often you need to be treated . your dose will be adjusted by your doctor . your eye doctor will tell you how much medicine you need . macug must be used in combination with antibiotic eye drops . your eyes will be treated with some local anaesthetic ( numbing medicine ) to
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these symptoms ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe of
what kepivance is kepvelance contains the active substance palifermin , which is produced by biotechnology in the plant called escherichia coli . palifermine works by stopping the growth of epithelial cells in the mouth and in the digestive tract , which are tissues that line the skin . palfermin is used to treat adults with oral mucositis ( soreness , dryness or inflammation of the mouth ), a common side effect that occurs during treatments for your blood cancer . if your bloodcancer is not well controlled with chemotherapy , radiotherapy or autologoushematopoietic stem cell transplant
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepivalance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . kepivellance may be taken with heparin . if you have recently been given heparrin , tell your physician . pregnancy and breast - feeding kepvelance is not recommended if you plan to
how kepivance is given kepiperance will be given to you by a doctor experienced in cancer treatment . the recommended dose of kepivalance is 60 mg . your doctor will decide how much kepiveance you need . the dose will be calculated by your doctor based on kilogram body weight . it will be administered as an intravenous injection into a vein . how kepvelance is administered kepivanance is usually given once a week . you will be receiving kepotalance three days before chemotherapy ( chemotherapy and radiotherapy ) for three days after chemotherapy and then three days afterwards after chemotherapy (
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and in levels of digestive enzymes in the blood . the following side effects have been
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection . it is supplied in a pack containing 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitam which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinocalcate accordphara is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis or who are unable to eliminate waste products that increase the level of calcium in the bloodstream ( hypercalcaemia ). to treat parathy thyroid cancer
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcordpharma . warnings and precautions talk to your doctor or pharmacist before taking cincacal cet accordPHarma : - if any of these apply to you , tell your doctor before taking this medicine . - if : you have ever had seizures ( fits or convulsions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma should be taken orally with or without food . the tablets should be swallowed whole with some water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinacealcite accordphara is 30 mg once a day ( one tablet in the morning and one tablet of cinealcate accordpharm in the evening ). the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( fits ) if your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every 10 people )
what cinacalcet accordpharma contains - the active substance is cinacetalc . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacealcot ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinaconalcel accordpharma looks like and contents of the pack ciniac
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformined belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflo
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severely reduced kidney function . - if he / she has uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . - lactic acidosis ( see section " risk of lacticacidosis " below ). what is ketoacidosis ? keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metforman , you should continue to take this medication until your doctor tells you otherwise . if this medicine does not work well enough to prevent an upset stomach , you may need to take 5 mg linaglptin or 2 , 000 mg metformina hydrochloride twice a day . your doctor may prescribe jentabueto alone if your blood sugar
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion . hypoglycemia is very rare ( may affect up to 1 in 10 , 000 people ). this side effect has been reported with jentADueto plus sulphonylurea . if you are treated with the combination j
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). blister : store in the original package in order to protect from light . do this medicine if you notice any change in the appearance of the tablets or if there are any signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochlorides . eachjentaduketo 2. 5 mg and 1 , 000 mg film film - coating contains 2. 25 mg of linaglinptin and 1, 000 mg metin hydroxychloride respectively . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , coll
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants does not cure hiv . it is used in combination with hiv medicine in adults and adolescents aged 12 and older , who are still infected with hick . your doctor will discuss with you whether edurent is suitable for you . if you have any further questions on the use of
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and seizures ) rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomeprazole
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 18 years and over ) edurant is not recommended for use in children and adolescents under 18 years of age . edurants contains the active substance rifabutin . this is a medicine used to treat some bacterial infections . edhurant contains rifabeutin in the tablet . if you take more edurent than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with food . do not take ed
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or problems with your routine liver tests . transaminase ( increase in cholesterol and pancreatic amylase in your blood ). abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body , triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpalpiviraine hydrochloride . each film - coated tablet of edurants contains rrilpivireine hydro chloride equivalent to 25 mg rilpaivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . film - coating : lactate monohydrate and hypromellose 2910 ( e464 ).
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don ' ts make enough of a medicine called rosaiglitrazone and meetformin , which are not able to work together . when rosigslitazONE and met formin are used together , the insulin that your body makes does not work as well as it should . this helps your body make better use of it . avand
follow all the doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . how to treat your diabetes your doctor will tell you what dose of avandamet you need . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes causing rapid weight
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( 1000 mg ) metformin twice a day . this dose is achieved gradually over 1 to 8 weeks . the maximum dose is 4 mg rosciglitrazone ( 1200 mg ) once a day , with metforman . thisdose is achieved slowly over 1 or 8 weeks , but your doctor may increase the dose to the maximum dosage of 4 mg once a daily . your doctor will also prescribe ro
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamand and seek medical advice straight away . lactic acidosis this is a rare but serious complication of lacticacidosis which occurs when substances in the blood ( lactic acids ) accumulate in the urine . the most common side effect with metformin is severe kidney disease
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigliglitasone and 500 mg metforman . each 2 mg tablet contains rosigslitazon and 500mg metforma . each 3 mg tablet contain 2 mg rosaiglitazaone and 1000 mg met formin . each 4 mg tablet also contains rosaiglig litazone , 1000 mg and met formformin ( see section 4 for further information ). the other ingredients are : sodium starch glycoll
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopideogrel has been shown to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of them apply to your ( or you are not sure ), talk to the doctor or nurse
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopideogrel Mylan contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ). it is used as a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets . platelets are blood cells that help the blood to clot and stop bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). if you have had blood clots in the veins or arteries . if you think blood cl clots may be serious . if blood clubs may be fatal . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using doptelelet if : you have cancer . you are taking the contraceptive birth control pill or hormone replacement therapy . you have recently had surgery or are seriously injured . you weigh less than 23 kg . you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to 8 mg once a week . your dose may be adjusted by your doctor depending on your response to doptelet . your daily dose of doptelets may be either 20 mg , 40 mg or 60 mg ( two 5 mg tablets ) once a daily . your physician will adjust your dose depending on the severity of your platelet counts . if you take more dopteol than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by blocking the action of the heart arteries , thus increasing heart rate and the muscles in the heart . rapiscan is used for the following types of heart scan : ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken by scanning the muscles of the inside of the main heart using a readmill . a scan contains a small amount of radiopharma that is injected into the body through a vein . this medicine is used to obtain images of the inner heart ,
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease or a pacemaker . if you experience chest pain ( unstable angina ) during treatment , you should tell your doctor . if your doctor has prescribed rapiscin if you : have low blood pressure ( hypotension ) or heart failure . are allergic to regadenoson . if any of the above applies to you ( or you are not sure ), talk to your doctor before using rapiscen . warnings and precautions talk to you doctor before you are given rapiscican if : you have a recent serious heart problem
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 minutes . your doctor will decide how much rapiscan you need and how much you need . the dose may be adjusted by your doctor depending on your weight . your dose may also be adjusted with an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( 0 .. 5 ml ) or
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection and usually disappear within 30 days without any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscans may cause a stroke ( cerebrovascular accident ) or an
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . pde 5 works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viagagra is a treatment for adult men with erectile dysfunction ( impotence ), a condition in which a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed medicines containing nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been prescribed any of these medicines , please contact your doctor . - if the doctor has recently prescribed nitric oxide donors such as amyl nitrite , which may lead to an increased risk of a dangerous drop in yourblood pressure . - when rioc
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . viagra film - coated tablets are also available as viagra orodispersible tablets . take viagra with food . swallow the tablets whole with a glass of water . viagagra can be taken with or without food . viaga may help you to get an erection if you continue to take it , even if you feel sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . the most serious side effects that have been reported with the use of viagra include : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat . chest pains may be severe and may require immediate medical attention . if you are in a semi - sitting position , you should use nitrates to relieve your chest pain . prolonged and sometimes painful erections (
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildeneafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : treat the symptoms of primary parkinson ' s disease in adults ; in adolescents ; in children ; in adults . it is used in combination with levodopa to treat parkinson '. treat the symptom of moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifol . - if your doctor has told you that you have any medical conditions or symptoms that could be associated with kidney disease . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has not been shown to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets taken once a day . during the first week , the usual starting dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg per day ). your doctor may increase your dose to 1 tablet sifol 0 .088 mg ( 1 . 264 mmol / day ) if your symptoms return but do not stop taking tablets , your doctor will increase your starting dose to the recommended 1 tablet once a daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may effect up to1 in 1 , 000 people rare : may affects up to one in 10 , 000 patients with parkinson ' s disease the following side effects have been reported : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations ( seeing , hearing
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole ( as 0 . 125 mg , in 0 . 25 mg , and in 0. 5 mg , respectively ). the other ingredients are : 1 mg pramsipexol dihydrochloride monohydrate , mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in the eye , depending on the severity of the allergic reaction . allergic conjustivitis may occur when you are exposed to some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling . these may be on the surface of your eye and you may feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadin : - if the medicine contains benzalkonium chloride . emadino contains benzaldehyde . see section 6 . this medicine has not been shown in clinical trials in patients treated with emadined . - if there are kidney or liver problems . warnings , precautions and precautions tell your doctor , pharmacist or nurse before using this medicine . other medicines
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults ( 12 years of age and older ) the recommended dose is one drop in the affected eye each day . this medicine is for use in both eyes . use in infants ( 12 months of age ) and children ( 12 to 17 years ) use in the following children and adolescent use in adolescents is not recommended . children and teenagers use in this age group the recommended starting dose is 1 drop twice
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects may be more serious if the drops are used too often . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in adults ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornealing staining , dry eye . general side effects : headache , difficulty sleeping , sinus headache
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide ( for acidity levels and ph levels ). what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). leveiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leveriracetamer has been
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported in patients treated with anti - epileptics . levetiaracetam actsavis may cause thoughts of harming or killing themselves . tell your physician if you or your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose in adults and adolescents from 16 years of age : one tablet once a day ( monotherapy ) the recommended starting dose is 1 , 000 mg once a week ( monothermedicated ) for 3 weeks . your doctor may increase your dose of leveriraceta actavis to 2 tablets once a daily ( monorid ) for 1 , 500 mg once daily .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms and a rash on the face with an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests . reduction in a type of white blood cell 56 ( eosinophilia ) and
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each film - coated tablet contains 250 mg of levetiroacetam ( as levetviracetam ). levetraracetam actingavis 500 mg : one film - coating tablet contains 500 mg of the active ingredient levetiralacetam. levetracetam actedavis 750 mg : every film - covered tablet contains 750 mg of of leveiracetamine ( as besilate ). leveriraceta actavis 1 , 000 mg : the active substances are
celemide contains the active substance umeclidinium bromide which belongs to a group of bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become damaged and difficult to use . this leads to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine blocks the tightening of these muscles , making it easier for air to get in and out of the lungs . this helps to control your breathing difficulties and helps to
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using incrusey ellipta : if you have asthma . incruche ellipta should not be used in patients with asthma . if you suffer from heart problems . if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). if you know that you suffer severe liver problems .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not change your dose unless your doctor tells you to . if you use more incruse ellipta than you should if you have used more inculse elliptas than you have been told to , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead . these could be signs for
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the active substance of the medicine should be discarded . once opened , use the inhaluer within 30 . do away with
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia . each dose delivers 65 microgramms umechloridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incruare ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body with a light green mouthpiece
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this is a type of protein that recognises and attaches to specific proteins in the body . what nucalo is used for nucalan is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the lungs to open ) in patients with eosynophilic asthma . asthma nucalin is used in adults to prevent asthma attacks and to reduce the use of medicines called high dose inhal
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to stop nucal or stop your treatment with nucalan . if your asthma does not respond to nuca treatment , tell your doctor . allergic and injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions to other parts of your body ( see section 4 possible
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a week . children and adolescents 1 year of age or older : your doctor will decide the dose that is right for you . the pre - filled pen is for single use only . your doctor or nurse will show you how to use nucala . duration of treatment your doctor may decide to continue to give nucale for as long as you are benefiting from the treatment . your dose of nucal will be adjusted by your doctor depending on your asthma symptoms and on how
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe . symptoms include chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to a similar reaction that you have experienced with nac
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucalo pre -filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . do away with the pre pre - fill pen once you have removed it from the refrigerator and it is within 7 hours of the time you put it back in the refrigerator .
what nucala contains - the active substance is mepolizumab . 1 ml solution contains 100 mg of mepolzumab - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is supplied as a pack containing 1 vial or a multipack containing 3 vials or 1 vials . not all pack sizes may be marketed .
what ninlaro is and how it works ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib inhibits cell survival and keeps myelomas cells growing by stopping the growth of a lot of proteins called proteasomes . what it does with ninlalo if you have multiple myelo , your doctor will prescribe you a medicine to help treat it . how does multiple myelinoma work ? ninlero is given
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions : bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , such as tingling , numbness , swelling or a persistent rash . liver or kidney problems your doctor may decide to reduce the dose of treatment with ninlara or stop treatment . your doctor will do blood tests to check that you have enough blood
instructions for use and handling of this medicine are given at the end of this leaflet . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . ninlaro must be taken with lenalidomide ( a medicine that contains dexamethasone ), an anti - inflammatory medicine . the recommended dose of ninlara is lenalidomeide and dexamETHasone once a day for the first 3 weeks . for the 4 - week course , you will take lenalidomonide 25 mg capsules once a morning on the same day of the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds or easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the surface of the body ). rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store the capsule in the original package in order to protect from moisture . do this medicine only if you notice any damage to the pack or medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixasomib and 3 . 3mg ixabomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - the capsule content contains : ixar 3 mg / ixezomib ( 3 mg ) and
do not use palforzia : if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palfiorzia ( listed in section 6 ). children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because peanut ( desensitisation ) is not a natural defence mechanism . palfORzia is not intended to cause allergic reactions . poforzial is used to treat food allergies . if you have any further questions on the use of pelforzias , ask your doctor or pharmacist .
do not take palforzia if you are allergic to peanut or soya if you have severe asthma if your asthma is not controlled with palfourzia , if you think you have a problem swallowing , if there are long term problems with your digestive system , if your doctor has told you that you have or have had a severe mast cell disorder , if severe or life - threatening anaphylaxis has occurred within 60 days of starting treatment . if this applies to you , tell your doctor before taking palfurzia . warnings and precautions talk to your doctor or pharmacist before taking any palfORz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have allergy , allergic reactions ( anaphylaxis ) may occur within 3 hours of starting treatment with palforzia . initial doseescalation is usually given at the start of these treatment steps . the initial dose elevation and up - dosing steps should be repeated every 3 weeks . your doctor will decide how long you should continue treatment with the combination of palfiorzia and initial dose escalation . these treatment phases should be initiated
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions if you have any of the following symptoms , stop taking palfORzia and seek medical help immediately : - the reaction may include : - trouble breathing - throat tightness - feeling offulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea - severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eos
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palforbz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules for opening microcrycrystallrine cellulose ( e460 ), colloidal Anhydroussilica and and magnesium strearate pregelatinised palfORzia 300 mg oralpowder in sachet microcry crystalline celluloses ( e463 ), colloid anhydrated sil
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it is used in combination with hypnotic actions to help you sleep . it has been shown to reduce sleeping problems in adults . it may also improve the quality of your sleep . your doctor will decide how long you should continue treatment . if you do not respond to treatment , you may have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes you to feel very weak , tired muscles , severe breathing or chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . other medicines and zere
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule once a day . if you have difficulty falling asleep , do not take the capsule . if your doctor tells you to : - are 65 years of age or older - have mild to moderate liver problems - are over 65 years old - have moderate to moderate kidney problems - take the capsules once a morning , at about the same time each day . - take one 5 mg capsule twice a day , at approximately the same times each day , with or without food . the
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or nurse if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare (> 1 user per 10 ,000 ) not known ( frequency cannot be estimated from the available data ). very common : may affect more
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - the printing ink contains gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphacy ( e133 ), silicon dioxide , ( s - 13050 ). - printing ink containing shellac
